Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coregulator activity	BCL9L PPRC1 NUP98 MAML1 NFKBIZ BCL11A BCL3 RAD54L2 BCL9 ARID1A NUPR1 MED15 TOB1 TRIM28 BRD4 MED12L MAP3K10 NCOA1 MYOCD RERE MED23 KAT6B MAML3 MRTFA	3.43e-10	562	182	24	GO:0003712
GeneOntologyMolecularFunction	transcription coactivator activity	BCL9L PPRC1 NUP98 MAML1 BCL3 BCL9 ARID1A NUPR1 TRIM28 BRD4 MED12L NCOA1 MYOCD RERE MED23 KAT6B MAML3 MRTFA	3.68e-10	303	182	18	GO:0003713
GeneOntologyMolecularFunction	chromatin binding	FOXO3 SATB2 BCAS3 PATZ1 ESR1 NUP98 ARID1A NUPR1 GRHL2 BAHD1 PHC3 TRIM28 GLI2 TP63 BRD4 TTC21B NCOA1 KMT2A PAX3 RERE ACTRT1 KAT6B SMAD3 CRTC2	6.95e-08	739	182	24	GO:0003682
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	FOXJ2 FOXO3 FOXN1 SATB2 VEZF1 PATZ1 ESR1 ETV1 MLXIP RREB1 GRHL2 STAT6 MLXIPL USF3 ZNF341 GLI2 TP63 ONECUT3 NOTCH2 SMAD3	2.49e-07	566	182	20	GO:0001216
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	FOXJ2 FOXO3 FOXN1 SATB2 VEZF1 PATZ1 ESR1 ETV1 MLXIP RREB1 GRHL2 STAT6 MLXIPL USF3 GLI2 TP63 ONECUT3 NOTCH2 SMAD3	9.31e-07	560	182	19	GO:0001228
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	BCL9L SH2B3 PPRC1 ATG2B NUP98 MAML1 NFKBIZ BCL11A BCL3 RAD54L2 BCL9 ARID1A NUPR1 MED15 TOB1 BAZ2A TRIM28 BRD4 GAB4 MED12L MAP3K10 NCOA1 MYOCD RERE MED23 KAT6B MAML3 MRTFA	2.23e-06	1160	182	28	GO:0030674
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	FOXJ2 FOXO3 FOXN1 POU6F2 SATB2 HIVEP1 VEZF1 PATZ1 ESR1 ETV1 KLF3 BCL11A MLXIP RREB1 GRHL2 STAT6 PKNOX2 MLXIPL FOXP4 USF3 ZNF341 LMX1B GLI2 TP63 PROX2 ZSCAN5C ZFHX2 PAX3 ONECUT3 NOTCH2 SMAD3	4.26e-06	1412	182	31	GO:0000981
GeneOntologyMolecularFunction	transcription factor binding	FOXO3 WFS1 PPRC1 BCAS3 ESR1 BCL11A BCL3 ARID1A GRHL2 STAT6 MLXIPL BAZ2A MED12L MAP3K10 NCOA1 KMT2A MYOCD PAX3 NOTCH2 SMAD3 CRTC2	5.44e-06	753	182	21	GO:0008134
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	FOXJ2 FOXO3 POU6F2 SATB2 HIVEP1 VEZF1 PATZ1 ESR1 ETV1 KLF3 NFKBIZ BCL11A MLXIP RREB1 GRHL2 STAT6 PKNOX2 MLXIPL FOXP4 USF3 ZNF341 LMX1B GLI2 TP63 PROX2 ZSCAN5C ZFHX2 NCOA1 PAX3 ONECUT3 SMAD3	8.25e-06	1459	182	31	GO:0000977
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	FOXJ2 FOXO3 POU6F2 SATB2 HIVEP1 PATZ1 ESR1 ETV1 KLF3 NFKBIZ BCL11A MLXIP RREB1 GRHL2 STAT6 PKNOX2 MLXIPL FOXP4 ZNF341 GLI2 TP63 PROX2 ZSCAN5C ZFHX2 PAX3 ONECUT3 NOTCH2 SMAD3	1.25e-05	1271	182	28	GO:0000987
GeneOntologyMolecularFunction	molecular adaptor activity	BCL9L SH2B3 PPRC1 ATG2B NUP98 MAML1 NFKBIZ BCL11A BCL3 RAD54L2 BCL9 ARID1A NUPR1 MED15 TOB1 BAZ2A TRIM28 BRD4 GAB4 MED12L MAP3K10 NCOA1 MYOCD RERE MED23 KAT6B BAG6 MAML3 MRTFA	1.49e-05	1356	182	29	GO:0060090
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	FOXJ2 FOXO3 POU6F2 SATB2 HIVEP1 PATZ1 ESR1 ETV1 KLF3 NFKBIZ BCL11A MLXIP RREB1 GRHL2 STAT6 PKNOX2 MLXIPL FOXP4 ZNF341 GLI2 TP63 PROX2 ZSCAN5C ZFHX2 PAX3 ONECUT3 SMAD3	2.36e-05	1244	182	27	GO:0000978
GeneOntologyMolecularFunction	structural constituent of nuclear pore	NUP98 POM121L2 NUP35 NUP155	7.27e-05	25	182	4	GO:0017056
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	WFS1 BCAS3 ESR1 BCL11A BCL3 ARID1A GRHL2 MLXIPL BAZ2A MAP3K10 NCOA1 KMT2A MYOCD NOTCH2 SMAD3 CRTC2	8.94e-05	582	182	16	GO:0140297
GeneOntologyMolecularFunction	promoter-specific chromatin binding	ESR1 NUP98 TRIM28 GLI2 TP63 SMAD3	1.11e-04	83	182	6	GO:1990841
GeneOntologyMolecularFunction	co-SMAD binding	USP9X USP9Y SMAD3	1.54e-04	12	182	3	GO:0070410
GeneOntologyMolecularFunction	acetyltransferase activator activity	BCAS3 NUPR1	4.90e-04	4	182	2	GO:0010698
GeneOntologyMolecularFunction	beta-catenin binding	FOXO3 BCL9L ESR1 BCL9 MED12L SMAD3	8.17e-04	120	182	6	GO:0008013
GeneOntologyMolecularFunction	SMAD binding	USP9X USP9Y TOB1 MYOCD SMAD3	1.14e-03	86	182	5	GO:0046332
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	FOXJ2 FOXO3 FOXN1 BCL9L SATB2 HIVEP1 VEZF1 PPRC1 BCAS3 PATZ1 ESR1 MAML1 ETV1 NFKBIZ BCL3 RAD54L2 MLXIP RREB1 BCL9 GRHL2 STAT6 MED15 MLXIPL USF3 LMX1B GLI2 TP63 BRD4 MED12L NCOA1 KMT2A MYOCD PAX3 CKAP2 ONECUT3 MED23 KAT6B MAML3 NOTCH2 MRTFA SMAD3 CRTC2	7.94e-13	1390	180	42	GO:0045944
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	FOXO3 SATB2 HIVEP1 WFS1 PATZ1 USP9X ESR1 KLF3 BCL11A BCL3 RREB1 ARID1A TRIM29 ATXN1L TENM2 BAHD1 STAT6 MLXIPL PHC3 FOXP4 TOB1 MAGED4 BAZ2A TRIM28 GLI2 TP63 MAP3K10 MYOCD PAX3 RERE MAGEC1 ACTRT1 KAT6B NOTCH2 SMAD3	1.32e-08	1399	180	35	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	FOXO3 SATB2 HIVEP1 WFS1 PATZ1 USP9X ESR1 KLF3 BCL11A BCL3 RREB1 ARID1A TRIM29 ATXN1L TENM2 BAHD1 STAT6 MLXIPL PHC3 FOXP4 TOB1 MAGED4 BAZ2A TRIM28 GLI2 TP63 MAP3K10 MYOCD PAX3 RERE MAGEC1 ACTRT1 KAT6B NOTCH2 SMAD3	1.70e-08	1413	180	35	GO:1902679
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	FOXO3 SATB2 HIVEP1 WFS1 PATZ1 USP9X ESR1 KLF3 BCL11A RREB1 ARID1A TRIM29 ATXN1L TENM2 STAT6 MLXIPL FOXP4 MAGED4 TRIM28 GLI2 TP63 MYOCD PAX3 MAGEC1 NOTCH2 SMAD3	1.61e-06	1053	180	26	GO:0000122
GeneOntologyBiologicalProcess	miRNA metabolic process	FOXO3 ESR1 AGO4 MYOCD TENT2 NOTCH2 MRTFA SMAD3	9.90e-06	119	180	8	GO:0010586
GeneOntologyBiologicalProcess	protein-DNA complex organization	SATB2 BICRA ESR1 SMARCAL1 NFKBIZ RAD54L2 ARID1A BAHD1 MED15 KANSL2 UBR5 BAZ2A TRIM28 TP63 BRD4 NCOA1 KMT2A MYOCD RERE GNAS MED23 KAT6B BAG6	2.09e-05	999	180	23	GO:0071824
GeneOntologyBiologicalProcess	chromatin remodeling	SATB2 BICRA ESR1 SMARCAL1 NFKBIZ RAD54L2 ARID1A BAHD1 UBR5 BAZ2A TRIM28 TP63 BRD4 NCOA1 KMT2A MYOCD RERE GNAS KAT6B	2.73e-05	741	180	19	GO:0006338
GeneOntologyBiologicalProcess	T cell differentiation	FOXO3 FOXN1 SH2B3 PATZ1 NFKBIZ BCL11A BCL3 ARID1A STAT6 LGALS9 GLI2 BRD4 KMT2A	3.26e-05	382	180	13	GO:0030217
GeneOntologyBiologicalProcess	regulation of miRNA metabolic process	FOXO3 ESR1 MYOCD TENT2 NOTCH2 MRTFA SMAD3	3.36e-05	103	180	7	GO:2000628
GeneOntologyBiologicalProcess	chromatin organization	SATB2 BICRA ESR1 SMARCAL1 NFKBIZ RAD54L2 ARID1A BAHD1 KANSL2 UBR5 BAZ2A TRIM28 TP63 BRD4 NCOA1 KMT2A MYOCD RERE GNAS KAT6B BAG6	3.80e-05	896	180	21	GO:0006325
GeneOntologyBiologicalProcess	regulation of miRNA transcription	FOXO3 ESR1 MYOCD NOTCH2 MRTFA SMAD3	8.79e-05	83	180	6	GO:1902893
GeneOntologyBiologicalProcess	miRNA transcription	FOXO3 ESR1 MYOCD NOTCH2 MRTFA SMAD3	9.40e-05	84	180	6	GO:0061614
GeneOntologyBiologicalProcess	developmental growth	FOXO3 RAPH1 MAP2 USP9X ESR1 BCL11A SIK3 BCL9 GRHL2 LATS2 LMX1B TRIM28 GLI2 BRD4 AFDN MYOCD RIMS1 GNAS NOTCH2 SMAD3	1.43e-04	911	180	20	GO:0048589
GeneOntologyBiologicalProcess	limb development	FOXN1 MBNL1 SIK3 GRHL2 LMX1B GLI2 TP63 GNAS NOTCH2	1.60e-04	224	180	9	GO:0060173
GeneOntologyBiologicalProcess	appendage development	FOXN1 MBNL1 SIK3 GRHL2 LMX1B GLI2 TP63 GNAS NOTCH2	1.60e-04	224	180	9	GO:0048736
GeneOntologyBiologicalProcess	CD4-positive, alpha-beta T cell differentiation involved in immune response	NFKBIZ BCL3 STAT6 LGALS9 BRD4 KMT2A	1.75e-04	94	180	6	GO:0002294
GeneOntologyBiologicalProcess	alpha-beta T cell differentiation involved in immune response	NFKBIZ BCL3 STAT6 LGALS9 BRD4 KMT2A	1.86e-04	95	180	6	GO:0002293
GeneOntologyBiologicalProcess	positive regulation of miRNA transcription	FOXO3 MYOCD NOTCH2 MRTFA SMAD3	1.92e-04	61	180	5	GO:1902895
GeneOntologyBiologicalProcess	alpha-beta T cell activation involved in immune response	NFKBIZ BCL3 STAT6 LGALS9 BRD4 KMT2A	2.20e-04	98	180	6	GO:0002287
GeneOntologyBiologicalProcess	appendage morphogenesis	MBNL1 SIK3 GRHL2 LMX1B GLI2 TP63 GNAS NOTCH2	2.26e-04	185	180	8	GO:0035107
GeneOntologyBiologicalProcess	limb morphogenesis	MBNL1 SIK3 GRHL2 LMX1B GLI2 TP63 GNAS NOTCH2	2.26e-04	185	180	8	GO:0035108
GeneOntologyBiologicalProcess	lymphocyte differentiation	FOXO3 FOXN1 SH2B3 PATZ1 NFKBIZ BCL11A BCL3 ARID1A STAT6 LGALS9 GLI2 BRD4 KMT2A NOTCH2	2.74e-04	537	180	14	GO:0030098
GeneOntologyBiologicalProcess	T cell differentiation involved in immune response	NFKBIZ BCL3 STAT6 LGALS9 BRD4 KMT2A	2.88e-04	103	180	6	GO:0002292
GeneOntologyBiologicalProcess	protein import into nucleus	NUP98 POM121L2 BCL3 NUP35 NUP155 UBR5 TRIM28 SMAD3	3.23e-04	195	180	8	GO:0006606
GeneOntologyBiologicalProcess	embryonic limb morphogenesis	MBNL1 GRHL2 LMX1B GLI2 TP63 GNAS NOTCH2	3.26e-04	148	180	7	GO:0030326
GeneOntologyBiologicalProcess	embryonic appendage morphogenesis	MBNL1 GRHL2 LMX1B GLI2 TP63 GNAS NOTCH2	3.26e-04	148	180	7	GO:0035113
GeneOntologyCellularComponent	chromatin	FOXJ2 FOXO3 FOXN1 POU6F2 SATB2 BCAS3 BICRA ESR1 ETV1 KLF3 BCL11A MLXIP ARID1A GRHL2 STAT6 MLXIPL FOXP4 KANSL2 UBR5 BAZ2A LMX1B TRIM28 TP63 BRD4 PROX2 ZFHX2 NCOA1 MYOCD PAX3 ONECUT3 KAT6B SMAD3	1.53e-06	1480	182	32	GO:0000785
GeneOntologyCellularComponent	nuclear protein-containing complex	FOXO3 BCL9L SATB2 BICRA SMARCAL1 NUP98 POM121L2 BCL11A MLXIP BCL9 ARID1A DYDC2 BAHD1 NUP35 STAT6 MED15 MLXIPL PHC3 NUP155 BAZ2A TRIM28 BRD4 MED12L NCOA1 KMT2A MYOCD RERE MED23 TENT2 SMAD3	2.94e-06	1377	182	30	GO:0140513
GeneOntologyCellularComponent	transcription regulator complex	FOXO3 BCL9L SATB2 ESR1 MLXIP BCL9 STAT6 MED15 MLXIPL GTF3C2 TRIM28 NCOA1 MYOCD PAX3 ONECUT3 MED23 SMAD3	1.91e-05	596	182	17	GO:0005667
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	BCL9L MLXIP BCL9 STAT6 MED15 MLXIPL TRIM28 NCOA1 MYOCD MED23 SMAD3	2.78e-05	272	182	11	GO:0090575
HumanPheno	Abnormal nasal tip morphology	SATB2 BICRA USP9X SMARCAL1 BCL11A RREB1 ARID1A SCYL2 MLXIPL SEC24C LMX1B GLI2 TP63 MED12L KMT2A PAX3 RERE KAT6B	1.06e-06	386	66	18	HP:0000436
HumanPheno	Bulbous nose	SATB2 BICRA USP9X SMARCAL1 RREB1 SCYL2 SEC24C LMX1B MED12L KMT2A RERE KAT6B	7.73e-06	201	66	12	HP:0000414
HumanPheno	Platybasia	SIK3 RREB1 SEC24C NOTCH2	5.39e-05	17	66	4	HP:0002691
HumanPheno	Abnormal cardiac atrium morphology	VEZF1 BICRA USP9X SIK3 RREB1 ARID1A MLXIPL NUP155 SEC24C ZNF341 BRD4 KMT2A CFAP74 MYOCD PAX3 RERE MED23 KAT6B NOTCH2 SMAD3	6.16e-05	617	66	20	HP:0005120
Domain	RA	RAPGEF6 RAPH1 RIN1 AFDN ARHGAP20	2.27e-05	36	179	5	PF00788
Domain	RA	RAPGEF6 RAPH1 RIN1 AFDN ARHGAP20	2.60e-05	37	179	5	PS50200
Domain	RA_dom	RAPGEF6 RAPH1 RIN1 AFDN ARHGAP20	3.83e-05	40	179	5	IPR000159
Domain	BCL9	BCL9L BCL9	9.13e-05	2	179	2	PF11502
Domain	Bcl-9	BCL9L BCL9	9.13e-05	2	179	2	IPR015668
Domain	BCL9_beta-catenin-bd_dom	BCL9L BCL9	9.13e-05	2	179	2	IPR024670
Domain	RA	RAPGEF6 RAPH1 RIN1 AFDN	2.10e-04	31	179	4	SM00314
Domain	MamL-1	MAML1 MAML3	2.72e-04	3	179	2	SM01275
Domain	RGS-like_dom	ARHGEF11 ARHGEF1	2.72e-04	3	179	2	IPR015212
Domain	Neuroggenic_mastermind-like_N	MAML1 MAML3	2.72e-04	3	179	2	IPR019082
Domain	RGS-like	ARHGEF11 ARHGEF1	2.72e-04	3	179	2	PF09128
Domain	MamL-1	MAML1 MAML3	2.72e-04	3	179	2	PF09596
Domain	AT_hook	PATZ1 BAZ2A KMT2A	4.42e-04	16	179	3	PF02178
Domain	Znf_FYVE_PHD	TCF19 BAZ2A TRIM28 MTMR3 KMT2A RIMS1 KAT6B	5.45e-04	147	179	7	IPR011011
Domain	BROMODOMAIN_2	BAZ2A TRIM28 BRD4 KMT2A	6.26e-04	41	179	4	PS50014
Domain	Bromodomain	BAZ2A TRIM28 BRD4 KMT2A	6.87e-04	42	179	4	IPR001487
Domain	BROMO	BAZ2A TRIM28 BRD4 KMT2A	6.87e-04	42	179	4	SM00297
Domain	-	BAZ2A TRIM28 BRD4 KMT2A	6.87e-04	42	179	4	1.20.920.10
Domain	PHD	TCF19 BAZ2A TRIM28 KMT2A KAT6B	7.67e-04	75	179	5	PF00628
Domain	Znf_PHD-finger	TCF19 BAZ2A TRIM28 KMT2A KAT6B	9.72e-04	79	179	5	IPR019787
Domain	TF_fork_head_CS_2	FOXJ2 FOXO3 FOXN1 FOXP4	9.72e-04	46	179	4	IPR030456
Domain	TF_fork_head_CS_1	FOXJ2 FOXO3 FOXN1 FOXP4	1.06e-03	47	179	4	IPR018122
Domain	FH	FOXJ2 FOXO3 FOXN1 FOXP4	1.23e-03	49	179	4	SM00339
Domain	FORK_HEAD_1	FOXJ2 FOXO3 FOXN1 FOXP4	1.23e-03	49	179	4	PS00657
Domain	FORK_HEAD_2	FOXJ2 FOXO3 FOXN1 FOXP4	1.23e-03	49	179	4	PS00658
Domain	Fork_head_dom	FOXJ2 FOXO3 FOXN1 FOXP4	1.23e-03	49	179	4	IPR001766
Domain	FORK_HEAD_3	FOXJ2 FOXO3 FOXN1 FOXP4	1.23e-03	49	179	4	PS50039
Domain	Forkhead	FOXJ2 FOXO3 FOXN1 FOXP4	1.23e-03	49	179	4	PF00250
Domain	Sec23/24_helical_dom	SEC24A SEC24C	1.34e-03	6	179	2	IPR006900
Domain	Sec23_24_beta_S	SEC24A SEC24C	1.34e-03	6	179	2	IPR012990
Domain	zf-Sec23_Sec24	SEC24A SEC24C	1.34e-03	6	179	2	PF04810
Domain	Sec23_trunk	SEC24A SEC24C	1.34e-03	6	179	2	PF04811
Domain	Sec23_helical	SEC24A SEC24C	1.34e-03	6	179	2	PF04815
Domain	Sec23_BS	SEC24A SEC24C	1.34e-03	6	179	2	PF08033
Domain	Sec23/24_trunk_dom	SEC24A SEC24C	1.34e-03	6	179	2	IPR006896
Domain	Znf_Sec23_Sec24	SEC24A SEC24C	1.34e-03	6	179	2	IPR006895
Domain	PHD	TCF19 BAZ2A TRIM28 KMT2A KAT6B	1.66e-03	89	179	5	SM00249
Domain	Znf_PHD	TCF19 BAZ2A TRIM28 KMT2A KAT6B	1.83e-03	91	179	5	IPR001965
Domain	RPEL	MYOCD MRTFA	1.86e-03	7	179	2	PS51073
Domain	RPEL	MYOCD MRTFA	1.86e-03	7	179	2	SM00707
Domain	CUT	SATB2 ONECUT3	1.86e-03	7	179	2	PS51042
Domain	CUT	SATB2 ONECUT3	1.86e-03	7	179	2	PF02376
Domain	RPEL	MYOCD MRTFA	1.86e-03	7	179	2	PF02755
Domain	RPEL_repeat	MYOCD MRTFA	1.86e-03	7	179	2	IPR004018
Domain	CUT_dom	SATB2 ONECUT3	1.86e-03	7	179	2	IPR003350
Domain	CUT	SATB2 ONECUT3	1.86e-03	7	179	2	SM01109
Pathway	REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML1 MAML3 NOTCH2 SMAD3	2.64e-05	20	126	4	M27881
Pathway	REACTOME_SUMOYLATION	SATB2 ESR1 NUP98 NUP35 PHC3 NUP155 TRIM28 NCOA1 MRTFA	4.95e-05	189	126	9	M27214
Pathway	REACTOME_SUMOYLATION	SATB2 ESR1 NUP98 NUP35 PHC3 NUP155 NCOA1 MRTFA	1.37e-04	169	126	8	MM14919
Pathway	REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML1 MAML3 NOTCH2	1.45e-04	12	126	3	M27159
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380	MAML1 MAML3 NOTCH2	1.45e-04	12	126	3	M47532
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381	MAML1 MAML3 NOTCH2	1.45e-04	12	126	3	M47533
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382	MAML1 MAML3 NOTCH2	1.87e-04	13	126	3	M47534
Pubmed	A census of human transcription factors: function, expression and evolution.	FOXJ2 FOXO3 FOXN1 POU6F2 SATB2 HIVEP1 PATZ1 ESR1 ETV1 TSC22D2 MLXIP RREB1 GRHL2 STAT6 PKNOX2 MLXIPL FOXP4 USF3 LMX1B GLI2 TP63 PROX2 ZFHX2 NCOA1 KMT2A UNKL PAX3 RERE ONECUT3 SMAD3	1.19e-15	908	184	30	19274049
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FOXO3 RAPGEF6 SH2B3 PPRC1 BCAS3 MAPKAPK2 BICRA INPPL1 ADGRB2 MAML1 MUS81 ARHGAP17 PFAS MLXIP BCL9 ARID1A ARHGEF11 PLXNB2 BIRC6 BAHD1 ARHGEF10L LATS2 ZNF341 LMX1B TRIM28 BRD4 CSPG4 MTMR3 UNKL ARRDC2 NOTCH2	3.13e-14	1105	184	31	35748872
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	FOXJ2 HIVEP1 VEZF1 ESR1 MBNL1 ETV1 KLF3 BCL11A ARID1A GRHL2 BIRC6 PKNOX2 FOXP4 BAZ2A TRIM28 GLI2 BRD4 PROX2 ZFHX2 NCOA1 KMT2A AFDN PAX3 KAT6B MAML3	8.32e-14	709	184	25	22988430
Pubmed	Interaction network of human early embryonic transcription factors.	BCL9L SATB2 HIVEP1 BICRA NUP98 MAML1 KLF3 BCL11A RAD54L2 RREB1 BCL9 ARID1A ATXN1L MED15 FOXP4 NCOA1 KMT2A RERE	6.47e-13	351	184	18	38297188
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	BCL9L DSG2 MBNL1 NUP98 RAD54L2 BCL9 ARHGEF11 NUP35 MED15 LATS2 NUP155 AIPL1 NOTCH2 CRTC2	9.73e-13	180	184	14	35198878
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	BCL9L HIVEP1 POLH RBM26 MAML1 BCL9 ARID1A ATXN1L GRHL2 MED15 FOXP4 BRD4 NCOA1 KMT2A RERE KNL1	1.31e-12	268	184	16	33640491
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	RAPGEF6 BICRA ESR1 INPPL1 ASAP3 NUP98 TSC22D2 RAD54L2 BCL9 PKNOX2 PHC3 USF3 TOB1 NUP155 GLI2 TP63 MRTFA CRTC2	1.89e-11	430	184	18	35044719
Pubmed	Human transcription factor protein interaction networks.	BCL9L SATB2 HIVEP1 VEZF1 DTNA BICRA USP9X SEC24A ESR1 POLH MBNL1 NUP98 MAML1 KLF3 BCL11A RAD54L2 RREB1 BCL9 ARID1A ATXN1L MED15 RNF214 PHC3 FOXP4 KANSL2 GTF3C2 GLI2 NCOA1 KMT2A MRPL38 RERE	2.41e-11	1429	184	31	35140242
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	FOXO3 RAPGEF6 HIVEP1 RAPH1 MAP2 DSG2 BCAS3 PATZ1 SEC24A INPPL1 ARHGAP17 SIK3 MLXIP SPICE1 MLXIPL ARHGEF1 BRD4 MAP3K10 KMT2A AFDN GNAS CKAP2 NOTCH2 CRTC2	3.71e-11	861	184	24	36931259
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	FOXJ2 FOXO3 SATB2 HIVEP1 VEZF1 PATZ1 ESR1 MBNL1 RBM26 ETV1 KLF3 NFKBIZ BCL3 ARID1A GRHL2 BAZ2A TRIM28 BRD4 ZSCAN5C NCOA1 KAT6B MRTFA SMAD3	6.50e-11	808	184	23	20412781
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	SATB2 RAPGEF6 HIVEP1 RAPH1 POLH ATG2B RREB1 BIRC6 MSTO1 PHC3 GTF3C2 UBR5 BRD4 RERE MRTFA KNL1	9.56e-10	418	184	16	34709266
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RAPGEF6 HIVEP1 RAPH1 NUP98 RREB1 BCL9 SPICE1 PHC3 KANSL2 SEC24C BAZ2A TRIM28 BRD4 KMT2A AFDN RIMS1 RERE KAT6B BAG6 NOTCH2 MRTFA	1.10e-09	774	184	21	15302935
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	FOXO3 POU6F2 MAP2 BCAS3 MAPKAPK2 DTNA BICRA GOLM2 MBNL1 ETV1 ARID1A GRHL2 PKNOX2 FOXP4 USF3 LATS2 GLI2 TTC21B ZFHX2 RIMS1 RERE GNAS CKAP2 ZSWIM4 KAT6B MAML3 NOTCH2	2.40e-08	1489	184	27	28611215
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	FOXJ2 FOXO3 FOXN1 SATB2 BCAS3 PATZ1 SMARCAL1 RBM26 NUP98 MAML1 TRIM29 FOXP4 KANSL2 GTF3C2 UBR5 A2ML1 MRPL38 PAX3 NOTCH2 SMAD3	3.43e-08	857	184	20	25609649
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	FOXO3 SMAP1 RAPGEF6 RAPH1 BCAS3 MAPKAPK2 USP9X SEC24A INPPL1 RBM26 MAML1 MLXIP TRIM29 SPICE1 SCYL2 MLXIPL SEC24C UBR5 ARHGEF1 GNAS MRTFA CRTC2	3.72e-08	1038	184	22	26673895
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	FOXO3 VEZF1 BICRA USP9X INPPL1 SMARCAL1 MBNL1 RBM26 PFAS TSC22D2 HSD11B1L BIRC6 BAHD1 MSTO1 RNF214 MLXIPL UBR5 TRIM28 BRD4 NCOA1 KMT2A UNKL RERE BAG6 RGL4	4.04e-08	1327	184	25	32694731
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RAPGEF6 RAPH1 DSG2 USP9X ATG2B RBM26 ARID1A SCYL2 MED15 GTF3C2 BAZ2A TRIM28 BRD4 KMT2A AFDN MED23	4.41e-08	549	184	16	38280479
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	FOXJ2 POU6F2 TCF19 ESR1 MAML1 NFKBIZ MLXIP TRIM29 STAT6 PKNOX2 LMX1B TRIM28 TP63 MYOCD PAX3 RERE ZSWIM4 MAML3 MRTFA SMAD3	5.00e-08	877	184	20	20211142
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	SATB2 HIVEP1 VEZF1 BICRA MBNL1 RBM26 MAML1 BCL11A RAD54L2 RREB1 BCL9 ARID1A ATXN1L MED15 UBR5 BRD4 NCOA1 KMT2A MED23 BAG6 KNL1	4.53e-07	1103	184	21	34189442
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	FOXO3 BCL9L RAPGEF6 USP9X ARID1A BIRC6 SPICE1 LATS2 UBR5 MTMR3 AFDN NOTCH2 CRTC2	8.46e-07	446	184	13	24255178
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	BCAS3 INPPL1 BCL11A RREB1 BIRC6 SPICE1 SEC24C CEP83 TTC21B CKAP2	1.02e-06	251	184	10	29778605
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PFAS ARHGEF11 PLXNB2 BAZ2A MTMR3 RIMS1 KAT6B	1.43e-06	104	184	7	9205841
Pubmed	LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.	BCL9L BCL9 LATS2	1.45e-06	5	184	3	24360964
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	SATB2 HIVEP1 VEZF1 BICRA MAML1 RREB1 ARID1A MED15 PHC3 FOXP4 BRD4 NCOA1	1.59e-06	398	184	12	35016035
Pubmed	Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.	TCF19 WFS1 ETV1 ST6GAL1 BCL11A RREB1	2.36e-06	72	184	6	24509480
Pubmed	Architecture of the linker-scaffold in the nuclear pore.	NUP98 NUP35 NUP155	2.88e-06	6	184	3	35679425
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	PATZ1 USP9X ARID1A SCYL2 PHC3 FOXP4 UBR5 MAGEC1 TENT2 KNL1	2.90e-06	282	184	10	23667531
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	CACNA1E HIVEP1 BCAS3 PATZ1 STAT6 NCOA1 ANO7 UNKL CCDC17	4.61e-06	233	184	9	37704626
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	VEZF1 PATZ1 MBNL1 ARID1A MED15 FOXP4 NUP155 SEC24C GTF3C2 ARHGEF1 TENT2	5.00e-06	370	184	11	22922362
Pubmed	Mutations in Bcl9 and Pygo genes cause congenital heart defects by tissue-specific perturbation of Wnt/β-catenin signaling.	BCL9L BCL9 PAX3	5.02e-06	7	184	3	30366904
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SATB2 MTSS1 MAML1 SIK3 BAHD1 ARHGEF10L AGO4 NUP155 GTF3C2 MED12L MED23 ARHGAP20 KAT6B	5.47e-06	529	184	13	14621295
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	BCL9L SEC24A MBNL1 NUP98 MAML1 BCL9 ARID1A NUP35 MED15 NUP155 MAML3 CRTC2	6.53e-06	457	184	12	32344865
Pubmed	Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.	ESR1 TRIM28 NCOA1	8.00e-06	8	184	3	9774463
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DSG2 BICRA PATZ1 BCL11A SIK3 RREB1 ARID1A SLC5A11 FOXP4 UBR5 BAZ2A TRIM28 BRD4 LRRC8B RERE KAT6B TENT2 NOTCH2 KNL1	8.22e-06	1116	184	19	31753913
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	BCL9L NUP98 NFKBIZ ARID1A BIRC6 NUP35 GTF3C2 TRIM28 BRD4 KMT2A BAG6 SMAD3	8.47e-06	469	184	12	27634302
Pubmed	The COPII cargo adapter SEC24C is essential for neuronal homeostasis.	SATB2 MAP2 SEC24A SEC24C	1.03e-05	26	184	4	29939162
Pubmed	Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors.	MAML1 MAML3 NOTCH2	1.20e-05	9	184	3	12370315
Pubmed	Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer.	USP9X RBM26 ARID1A TRIM28 BRD4	1.31e-05	57	184	5	38223760
Pubmed	Subtypes of medulloblastoma have distinct developmental origins.	SATB2 PLXNB2 TRIM28 PAX3 NOTCH2	1.31e-05	57	184	5	21150899
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	SATB2 RAD54L2 RREB1 ATXN1L MLXIPL NUP155 SEC24C GTF3C2 BAZ2A LMX1B TRIM28 PAX3 SMAD3	1.53e-05	583	184	13	29844126
Pubmed	The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development.	ARHGAP17 ARHGEF11 ARHGEF10L TP63 AFDN	1.56e-05	59	184	5	26371508
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	VGF CACNA1E PRR36 PATZ1 USP9X ADGRB2 BCL11A SIK3 BCL9 ARHGEF11 TENM2 SPICE1 SEC24C UBR5 TRIM28 AFDN RIMS1	1.59e-05	963	184	17	28671696
Pubmed	A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.	RAPH1 MAP2 DTNA MBNL1 MTMR3	1.69e-05	60	184	5	19075228
Pubmed	The core component of the mammalian SWI/SNF complex SMARCD3/BAF60c is a coactivator for the nuclear retinoic acid receptor.	ESR1 ARID1A NCOA1	1.70e-05	10	184	3	17363140
Pubmed	Functional proteomics mapping of a human signaling pathway.	HIVEP1 TRIM29 SCYL2 NUP155 UBR5 ZNF341 BRD4 CSPG4 AFDN BAG6 NOTCH2 SMAD3 KNL1	1.77e-05	591	184	13	15231748
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	FOXJ2 NUP98 MUS81 BCL11A RREB1 ARID1A TRIM29 MED15 RNF214	2.18e-05	283	184	9	18854154
Pubmed	Evidence that preaxial polydactyly in the Doublefoot mutant is due to ectopic Indian Hedgehog signaling.	LMX1B GLI2 PAX3	2.33e-05	11	184	3	9671585
Pubmed	Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.	ESR1 NCOA1	2.78e-05	2	184	2	11682626
Pubmed	IL-37 isoform D downregulates pro-inflammatory cytokines expression in a Smad3-dependent manner.	IL37 SMAD3	2.78e-05	2	184	2	29789615
Pubmed	IL-37 is a fundamental inhibitor of innate immunity.	IL37 SMAD3	2.78e-05	2	184	2	20935647
Pubmed	ARID1A loss derepresses a group of human endogenous retrovirus-H loci to modulate BRD4-dependent transcription.	ARID1A BRD4	2.78e-05	2	184	2	35715442
Pubmed	A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.	ESR1 NCOA1	2.78e-05	2	184	2	10598586
Pubmed	The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2.	ESR1 GRHL2	2.78e-05	2	184	2	30455249
Pubmed	ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2.	GLI2 TP63	2.78e-05	2	184	2	25085524
Pubmed	Rho GEF Lsc is required for normal polarization, migration, and adhesion of formyl-peptide-stimulated neutrophils.	ARHGEF11 ARHGEF1	2.78e-05	2	184	2	16263795
Pubmed	TP63 truncating mutation causes increased cell apoptosis and premature ovarian insufficiency by enhanced transcriptional activation of CLCA2.	CLCA2 TP63	2.78e-05	2	184	2	38528613
Pubmed	TRIM29 regulates the p63-mediated pathway in cervical cancer cells.	TRIM29 TP63	2.78e-05	2	184	2	26071105
Pubmed	p63 controls cell migration and invasion by transcriptional regulation of MTSS1.	MTSS1 TP63	2.78e-05	2	184	2	26119942
Pubmed	Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions.	BCL9L BCL9	2.78e-05	2	184	2	15371335
Pubmed	Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14).	KMT2A KNL1	2.78e-05	2	184	2	12618768
Pubmed	Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome.	USP9X USP9Y	2.78e-05	2	184	2	12895410
Pubmed	Molecular determinants of the estrogen receptor-coactivator interface.	ESR1 NCOA1	2.78e-05	2	184	2	10207113
Pubmed	SATB2 augments ΔNp63α in head and neck squamous cell carcinoma.	SATB2 TP63	2.78e-05	2	184	2	20829881
Pubmed	Validation of NG2 antigen in identifying BP-ALL patients with MLL rearrangements using qualitative and quantitative flow cytometry: a prospective study.	CSPG4 KMT2A	2.78e-05	2	184	2	17851550
Pubmed	A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis.	GRHL2 UBR5	2.78e-05	2	184	2	21949371
Pubmed	The p63 Gene Is Regulated by Grainyhead-like 2 (GRHL2) through Reciprocal Feedback and Determines the Epithelial Phenotype in Human Keratinocytes.	GRHL2 TP63	2.78e-05	2	184	2	26085095
Pubmed	Molecular mechanism of the inhibition of estradiol-induced endometrial epithelial cell proliferation by clomiphene citrate.	ESR1 NCOA1	2.78e-05	2	184	2	19934375
Pubmed	Deficiency of the transcriptional regulator p8 results in increased autophagy and apoptosis, and causes impaired heart function.	FOXO3 NUPR1	2.78e-05	2	184	2	20181828
Pubmed	Crystallization and preliminary crystallographic studies of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain.	STAT6 NCOA1	2.78e-05	2	184	2	14993689
Pubmed	Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module.	MLXIP MLXIPL	2.78e-05	2	184	2	16644671
Pubmed	Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.	MYOCD MRTFA	2.78e-05	2	184	2	31928221
Pubmed	The transcriptional coactivator Maml1 is required for Notch2-mediated marginal zone B-cell development.	MAML1 NOTCH2	2.78e-05	2	184	2	17699740
Pubmed	Contrasting Patterns in the Evolution of Vertebrate MLX Interacting Protein (MLXIP) and MLX Interacting Protein-Like (MLXIPL) Genes.	MLXIP MLXIPL	2.78e-05	2	184	2	26910886
Pubmed	Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells.	MYOCD MRTFA	2.78e-05	2	184	2	14970199
Pubmed	Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.	BCL9L BCL9	2.78e-05	2	184	2	38811552
Pubmed	Usp9y (ubiquitin-specific protease 9 gene on the Y) is associated with a functional promoter and encodes an intact open reading frame homologous to Usp9x that is under selective constraint.	USP9X USP9Y	2.78e-05	2	184	2	12925892
Pubmed	NUP98-MLL fusion in human acute myeloblastic leukemia.	NUP98 KMT2A	2.78e-05	2	184	2	20558618
Pubmed	Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase.	FOXO3 MYOCD	2.78e-05	2	184	2	18772130
Pubmed	Detection of ERalpha-SRC-1 interactions using bioluminescent resonance energy transfer.	ESR1 NCOA1	2.78e-05	2	184	2	19763509
Pubmed	The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.	FOXO3 ESR1	2.78e-05	2	184	2	24047697
Pubmed	Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation.	NCOA1 PAX3	2.78e-05	2	184	2	26371783
Pubmed	Nuclear translocation of MRTFA in MCF7 breast cancer cells shifts ERα nuclear/genomic to extra-nuclear/non genomic actions.	ESR1 MRTFA	2.78e-05	2	184	2	33894309
Pubmed	Suppression of NUPR1 in fibroblast-like synoviocytes reduces synovial fibrosis via the Smad3 pathway.	NUPR1 SMAD3	2.78e-05	2	184	2	39090667
Pubmed	Smad 3 regulates proliferation of the mouse ovarian surface epithelium.	ESR1 SMAD3	2.78e-05	2	184	2	12845704
Pubmed	Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.	NCOA1 PAX3	2.78e-05	2	184	2	15313887
Pubmed	Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor.	ESR1 NCOA1	2.78e-05	2	184	2	9427757
Pubmed	Genetic polymorphisms of LMX1B and MLXIP are associated with hip osteoarthritis in the Chinese population.	MLXIP LMX1B	2.78e-05	2	184	2	39263770
Pubmed	LATS2 is a modulator of estrogen receptor alpha.	ESR1 LATS2	2.78e-05	2	184	2	23267128
Pubmed	Stat6-independent tissue inflammation occurs selectively on the ocular surface and perioral skin of IkappaBzeta-/- mice.	NFKBIZ STAT6	2.78e-05	2	184	2	18441309
Pubmed	PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.	FOXO3 PAX3	2.78e-05	2	184	2	27458157
Pubmed	MondoA Is an Essential Glucose-Responsive Transcription Factor in Human Pancreatic β-Cells.	MLXIP MLXIPL	2.78e-05	2	184	2	29282201
Pubmed	Role of the p63-FoxN1 regulatory axis in thymic epithelial cell homeostasis during aging.	FOXN1 TP63	2.78e-05	2	184	2	24263106
Pubmed	Regulated localization is sufficient for hormonal control of regulator of G protein signaling homology Rho guanine nucleotide exchange factors (RH-RhoGEFs).	ARHGEF11 ARHGEF1	2.78e-05	2	184	2	24855647
Pubmed	BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.	BCL9L BCL9	2.78e-05	2	184	2	33767438
Pubmed	Genetic factors contributing to autism spectrum disorder in Williams-Beuren syndrome.	MLXIPL UBR5	2.78e-05	2	184	2	31413120
Pubmed	The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2.	USP9X USP9Y	2.78e-05	2	184	2	8922996
Pubmed	Modulation of myocardin function by the ubiquitin E3 ligase UBR5.	UBR5 MYOCD	2.78e-05	2	184	2	20167605
Pubmed	MBNL1 and MRTF-A form a positive feedback loop in regulating the migration of esophageal cancer cells.	MBNL1 MRTFA	2.78e-05	2	184	2	36204878
Pubmed	A close correlation in the expression patterns of Af-6 and Usp9x in Sertoli and granulosa cells of mouse testis and ovary.	USP9X AFDN	2.78e-05	2	184	2	15509704
Pubmed	Altered expression of WFS1 and NOTCH2 genes associated with diabetic nephropathy in T2DM patients.	WFS1 NOTCH2	2.78e-05	2	184	2	29626590
Interaction	TLE3 interactions	FOXJ2 BCL9L HIVEP1 VEZF1 SEC24A ESR1 POLH MBNL1 MAML1 KLF3 RAD54L2 BCL9 ARID1A ATXN1L NUP35 MED15 PHC3 UBR5 GLI2 BRD4 NCOA1 KMT2A RERE MED23 CRTC2 KNL1	5.51e-16	376	180	26	int:TLE3
Interaction	FEV interactions	SATB2 HIVEP1 VEZF1 BICRA MAML1 BCL11A RAD54L2 RREB1 BCL9 ARID1A ATXN1L PHC3 FOXP4 GTF3C2 KMT2A	4.38e-10	203	180	15	int:FEV
Interaction	EGR2 interactions	BCL9L HIVEP1 BICRA MAML1 BCL11A RAD54L2 RREB1 BCL9 ARID1A ATXN1L FOXP4 NCOA1 KMT2A RERE	4.43e-10	171	180	14	int:EGR2
Interaction	AR interactions	BCL9L HIVEP1 DSG2 PATZ1 ESR1 INPPL1 POLH RBM26 MAML1 RAD54L2 RREB1 BCL9 ARID1A ATXN1L GRHL2 MED15 FOXP4 LATS2 UBR5 TRIM28 GLI2 BRD4 MED12L NCOA1 KMT2A RERE GNAS MED23 BAG6 SMAD3 KNL1	1.01e-09	992	180	31	int:AR
Interaction	GSC interactions	BCL9L SATB2 HIVEP1 BCL11A RREB1 BCL9 ATXN1L FOXP4 RERE SMAD3	5.55e-09	87	180	10	int:GSC
Interaction	ERG interactions	SATB2 HIVEP1 BICRA USP9X MAML1 ETV1 RAD54L2 BCL9 ARID1A ATXN1L FOXP4 UBR5 BRD4 RERE	1.39e-08	223	180	14	int:ERG
Interaction	LHX6 interactions	BCL9L SATB2 HIVEP1 ATG2B KLF3 BCL9 ATXN1L LMX1B	4.54e-08	58	180	8	int:LHX6
Interaction	NFIB interactions	SATB2 HIVEP1 ESR1 MAML1 KLF3 BCL9 ARID1A ATXN1L NUP35 FOXP4 BRD4	6.15e-08	142	180	11	int:NFIB
Interaction	CRX interactions	BCL9L SMAP1 SATB2 BICRA MAML1 RREB1 BCL9 ARID1A ATXN1L MED15 FOXP4 NCOA1 RERE SMAD3	7.12e-08	254	180	14	int:CRX
Interaction	CTBP1 interactions	FOXO3 BCAS3 ESR1 MAML1 KLF3 BCL3 RREB1 ATXN1L NUPR1 MED15 PHC3 SEC24C BRD4 KMT2A UNKL MED23 BAG6	1.50e-07	406	180	17	int:CTBP1
Interaction	TSC1 interactions	FOXO3 POU6F2 VEZF1 PATZ1 USP9X SEC24A ESR1 BCL11A TENM2 RIN1 KANSL2 LATS2 NUP155 SEC24C TRIM28 TP63	1.98e-07	366	180	16	int:TSC1
Interaction	DTX2 interactions	BCL9L DSG2 MBNL1 NUP98 RAD54L2 BCL9 ARHGEF11 NUP35 MED15 LATS2 NUP155 AIPL1 TENT2 NOTCH2 CRTC2	2.95e-07	330	180	15	int:DTX2
Interaction	SMAD2 interactions	FOXO3 USP9X ESR1 SIK3 ARID1A MED15 RIN1 TOB1 LATS2 GTF3C2 UBR5 TRIM28 AFDN UNKL MYOCD SMAD3	3.91e-07	385	180	16	int:SMAD2
Interaction	NFIC interactions	SATB2 HIVEP1 SEC24A KLF3 RREB1 ARID1A ATXN1L NUP35 FOXP4 LATS2 BRD4 SMAD3	4.29e-07	210	180	12	int:NFIC
Interaction	NFYC interactions	FOXJ2 SMAP1 POU6F2 HIVEP1 BICRA NUPR1 KANSL2 USF3 KMT2A MED23 SMAD3	5.74e-07	177	180	11	int:NFYC
Interaction	HDAC1 interactions	SATB2 RAPGEF6 HIVEP1 RAPH1 BCAS3 ESR1 POLH ATG2B NUP98 BCL11A BCL3 RREB1 ARID1A NUPR1 BIRC6 BAHD1 LATS2 UBR5 BAZ2A TRIM28 GLI2 BRD4 KMT2A PAX3 RERE MRTFA SMAD3 KNL1	6.05e-07	1108	180	28	int:HDAC1
Interaction	TOP3B interactions	FOXO3 RAPGEF6 SH2B3 PPRC1 BCAS3 MAPKAPK2 BICRA SEC24A INPPL1 ADGRB2 MAML1 MUS81 ARHGAP17 PFAS MLXIP BCL9 ARID1A ARHGEF11 PLXNB2 BIRC6 BAHD1 ARHGEF10L LATS2 ZNF341 LMX1B TRIM28 BRD4 CSPG4 MTMR3 UNKL GNAS ARRDC2 NOTCH2	7.66e-07	1470	180	33	int:TOP3B
Interaction	TBR1 interactions	BCL9L SATB2 HIVEP1 MAML1 BCL9 ARID1A ATXN1L FOXP4 BRD4	7.96e-07	113	180	9	int:TBR1
Interaction	KDM1A interactions	SATB2 RAPGEF6 HIVEP1 RAPH1 USP9X ESR1 ATG2B KLF3 BCL3 RREB1 BIRC6 BAHD1 MSTO1 SPICE1 PHC3 GTF3C2 UBR5 TRIM28 BRD4 CEP70 UNKL RERE MED23 MRTFA KNL1	1.06e-06	941	180	25	int:KDM1A
Interaction	NUP35 interactions	BCL9L SEC24A ESR1 MBNL1 NUP98 MAML1 BCL9 ARID1A NUPR1 NUP35 MED15 NUP155 TRIM28 AFDN MAML3 CRTC2	1.39e-06	424	180	16	int:NUP35
Interaction	PAX9 interactions	BCL9L SATB2 MBNL1 MAML1 BCL11A BCL9 ARID1A ATXN1L FOXP4	2.58e-06	130	180	9	int:PAX9
Interaction	MED15 interactions	ESR1 NUP35 MED15 SEC24C BRD4 MED12L KMT2A MED23 SMAD3	2.75e-06	131	180	9	int:MED15
Interaction	SP7 interactions	BCL9L SATB2 HIVEP1 BICRA POLH MBNL1 MAML1 BCL9 ARID1A ATXN1L FOXP4 NCOA1 RERE	3.66e-06	304	180	13	int:SP7
Interaction	ZFHX3 interactions	POU6F2 HIVEP1 ESR1 KLF3 CEP70 MED23 DEUP1 SMAD3	6.11e-06	109	180	8	int:ZFHX3
Interaction	EP300 interactions	FOXO3 USP9X SEC24A ESR1 RBM26 NUP98 MAML1 ETV1 KLF3 BCL3 ARID1A NUPR1 BIRC6 MSTO1 NUP35 STAT6 MLXIPL SEC24C GTF3C2 TRIM28 TP63 BRD4 NCOA1 MYOCD RERE MED23 BAG6 MRTFA SMAD3 CRTC2	6.78e-06	1401	180	30	int:EP300
Interaction	PAX8 interactions	SATB2 HIVEP1 MAML1 BCL9 ARID1A ATXN1L FOXP4 SMAD3	6.99e-06	111	180	8	int:PAX8
Interaction	HNF4A interactions	SATB2 HIVEP1 BICRA ESR1 RAD54L2 RREB1 ARID1A KANSL2 GTF3C2 NCOA1 MED23 SMAD3	7.14e-06	275	180	12	int:HNF4A
Interaction	NFIA interactions	SATB2 HIVEP1 MAML1 KLF3 BCL9 ARID1A ATXN1L MED15 FOXP4 SMAD3	7.62e-06	188	180	10	int:NFIA
Interaction	HNF1B interactions	POU6F2 SATB2 HIVEP1 BICRA POLH MAML1 BCL9 ARID1A ATXN1L NUP35	8.36e-06	190	180	10	int:HNF1B
Interaction	RCOR1 interactions	SATB2 RAPGEF6 HIVEP1 RAPH1 POLH ATG2B KLF3 BCL3 RREB1 BIRC6 UBR5 TRIM28 BRD4 MED23 MRTFA KNL1	9.73e-06	494	180	16	int:RCOR1
Interaction	KLF5 interactions	HIVEP1 ESR1 MAML1 BCL9 ARID1A ATXN1L FOXP4 TP63 BRD4 SMAD3	1.05e-05	195	180	10	int:KLF5
Interaction	PAX7 interactions	SATB2 HIVEP1 MAML1 RREB1 BCL9 ARID1A ATXN1L FOXP4	1.58e-05	124	180	8	int:PAX7
Interaction	YWHAH interactions	FOXO3 RAPGEF6 HIVEP1 MAP2 DSG2 BCAS3 SEC24A ESR1 INPPL1 ARHGAP17 SIK3 MLXIP ATXN1L RIN1 MLXIPL LATS2 BRD4 MTMR3 MAP3K10 NCOA1 KMT2A AFDN RIMS1 NOTCH2 CRTC2	1.68e-05	1102	180	25	int:YWHAH
Interaction	KAT8 interactions	ESR1 KANSL2 BAZ2A BRD4 KMT2A RERE KAT6B	2.30e-05	95	180	7	int:KAT8
Interaction	MAML3 interactions	MAML1 NUP35 MAML3 NOTCH2	2.67e-05	20	180	4	int:MAML3
Interaction	WWTR1 interactions	RAPGEF6 RAPH1 DSG2 ATG2B ARID1A NUP35 SCYL2 LATS2 GTF3C2 TP63 BRD4 KMT2A AFDN PAX3	2.75e-05	422	180	14	int:WWTR1
Interaction	NOTCH4 interactions	MAML1 MAML3 NOTCH2 SMAD3	3.27e-05	21	180	4	int:NOTCH4
Interaction	MED6 interactions	ESR1 MED15 UBR5 BRD4 MED12L MED23 SMAD3	3.42e-05	101	180	7	int:MED6
Interaction	NFIX interactions	FOXN1 SATB2 HIVEP1 BICRA RREB1 ARID1A ATXN1L KANSL2 GTF3C2 KMT2A	3.88e-05	227	180	10	int:NFIX
Interaction	NCOA2 interactions	FOXJ2 ESR1 ETV1 NUP35 STAT6 UBR5 NCOA1 MED23	4.00e-05	141	180	8	int:NCOA2
Interaction	NUP160 interactions	NUP98 ARID1A NUPR1 NUP35 LGALS9 LATS2 NUP155 TRIM28 PACC1	4.06e-05	183	180	9	int:NUP160
Interaction	ZNF148 interactions	FOXJ2 POU6F2 INPPL1 KLF3 FOXP4 SEC24C CEP70 DEUP1	4.64e-05	144	180	8	int:ZNF148
Interaction	TNRC6B interactions	SEC24A ESR1 PFAS NUP35 RNF214 AGO4 LATS2 NUP155 GLI2 AFDN MED23	4.84e-05	282	180	11	int:TNRC6B
Interaction	EMSY interactions	FOXJ2 ESR1 NUP98 KLF3 PHC3 FOXP4 TRIM28 MED23	4.88e-05	145	180	8	int:EMSY
Interaction	STAT3 interactions	HIVEP1 MAPKAPK2 DTNA ESR1 MBNL1 NFKBIZ BCL3 SOCS7 STAT6 TRIM28 BRD4 CEP70 NCOA1 PACC1	5.01e-05	446	180	14	int:STAT3
Interaction	DCAF12 interactions	HIVEP1 MBNL1 BIRC6 RIN1 UBR5 MED23 KNL1	5.27e-05	108	180	7	int:DCAF12
Interaction	RRAS2 interactions	MUS81 LGALS4 LGALS9 RIN1 TRIM28 AFDN SMAD3	5.59e-05	109	180	7	int:RRAS2
Interaction	ZMYND8 interactions	FOXJ2 ESR1 BCL11A RREB1 TRIM28 BRD4 LRRC8B RERE NOTCH2	5.67e-05	191	180	9	int:ZMYND8
Interaction	MYOD1 interactions	HIVEP1 ESR1 BCL9 ARID1A NUPR1 MLXIPL NCOA1 MYOCD SMAD3	6.39e-05	194	180	9	int:MYOD1
Interaction	UBE2I interactions	VEZF1 ESR1 NUP98 ETV1 KLF3 BCL11A RAD54L2 TRIM29 NUPR1 NUP35 NUP155 TRIM28 GLI2 TP63 BRD4 KAT6B MRTFA	8.27e-05	654	180	17	int:UBE2I
Interaction	MED18 interactions	MED15 BRD4 MTMR3 MED12L CKAP2 MED23	8.70e-05	81	180	6	int:MED18
Interaction	SOX7 interactions	SATB2 MAML1 RREB1 ARID1A FOXP4 NCOA1	9.32e-05	82	180	6	int:SOX7
Interaction	CREBBP interactions	FOXO3 HIVEP1 ESR1 NUP98 MAML1 MUS81 BCL3 ARID1A NUP35 STAT6 TRIM28 BRD4 NCOA1 KMT2A MED23 SMAD3	9.85e-05	599	180	16	int:CREBBP
Interaction	SEC24C interactions	DTNA USP9X SEC24A LGALS9 MED15 SEC24C TRIM28 TP63 NOTCH2	1.05e-04	207	180	9	int:SEC24C
Interaction	MED13 interactions	ESR1 TSC22D2 MED15 BRD4 MED12L MED23	1.22e-04	86	180	6	int:MED13
Interaction	DCAF7 interactions	SEC24A ESR1 SMARCAL1 KLF3 RAD54L2 SOCS7 LATS2 NUP155 SEC24C BRD4 MED23 SMAD3	1.22e-04	368	180	12	int:DCAF7
Interaction	MYOCD interactions	UBR5 MYOCD MRTFA SMAD3	1.23e-04	29	180	4	int:MYOCD
Interaction	YWHAG interactions	FOXO3 RAPGEF6 HIVEP1 RAPH1 MAP2 DSG2 BCAS3 SEC24A ESR1 ARHGAP17 SIK3 MLXIP SPICE1 RIN1 MLXIPL LATS2 ARHGEF1 MTMR3 MAP3K10 KMT2A AFDN GNAS CKAP2 NOTCH2 CRTC2	1.26e-04	1248	180	25	int:YWHAG
Interaction	RUNX2 interactions	SATB2 MED15 BRD4 NCOA1 PAX3 KAT6B SMAD3	1.39e-04	126	180	7	int:RUNX2
Interaction	ZNF555 interactions	TRIM28 CEP70 NOTCH2	1.45e-04	12	180	3	int:ZNF555
Interaction	BAG2 interactions	SMAP1 RAPGEF6 MAPKAPK2 MBNL1 ARHGAP17 BCL3 RREB1 SCYL2 RNF214 PHC3 LATS2 GTF3C2 BRD4 CKAP2 MRTFA KNL1	1.52e-04	622	180	16	int:BAG2
Interaction	MED14 interactions	ESR1 MED15 UBR5 TRIM28 BRD4 MED12L KMT2A MED23	1.55e-04	171	180	8	int:MED14
Interaction	SOX2 interactions	BCL9L SATB2 HIVEP1 PATZ1 USP9X NUP98 MAML1 KLF3 BCL9 ARID1A TRIM29 ATXN1L ULBP3 SCYL2 PHC3 FOXP4 UBR5 TRIM28 TP63 A2ML1 KMT2A SLC45A2 CKAP2 MAGEC1 KAT6B TENT2 KNL1	1.60e-04	1422	180	27	int:SOX2
Interaction	UBE2C interactions	USP9X SEC24A TRIM29 TRIM28 BRD4 CKAP2	1.66e-04	91	180	6	int:UBE2C
Interaction	ZMYM2 interactions	FOXJ2 SATB2 ESR1 KLF3 TSC22D2 RAD54L2 RREB1 FOXP4 GTF3C2 SMAD3	1.69e-04	271	180	10	int:ZMYM2
Interaction	SOX10 interactions	POU6F2 HIVEP1 BCL9 ARID1A ATXN1L PAX3	1.76e-04	92	180	6	int:SOX10
Interaction	TLX1 interactions	SATB2 HIVEP1 MAML1 RREB1 BCL9 ARID1A ATXN1L FOXP4	1.81e-04	175	180	8	int:TLX1
Interaction	ZNF607 interactions	TRIM28 TP63 CEP70	1.88e-04	13	180	3	int:ZNF607
Interaction	TEAD1 interactions	SATB2 HIVEP1 RREB1 ARID1A ATXN1L NUP35 TP63 NCOA1	1.88e-04	176	180	8	int:TEAD1
Interaction	NCOA3 interactions	ESR1 ETV1 NUP35 STAT6 BRD4 NCOA1 MYOCD MRTFA SMAD3	1.90e-04	224	180	9	int:NCOA3
Interaction	SMAD3 interactions	FOXO3 HIVEP1 IL37 USP9X ESR1 SIK3 ARID1A MED15 TOB1 NCOA1 MYOCD MRTFA SMAD3	1.98e-04	447	180	13	int:SMAD3
Interaction	SNRNP40 interactions	BCL9L HIVEP1 VEZF1 POLH SMARCAL1 MBNL1 BCL9 ARID1A ATXN1L NUPR1 PHC3 UBR5 BAZ2A BRD4 KMT2A KNL1	1.99e-04	637	180	16	int:SNRNP40
Interaction	FASN interactions	VEZF1 BICRA USP9X INPPL1 SMARCAL1 MBNL1 RBM26 TSC22D2 HSD11B1L BIRC6 BAHD1 LGALS9 RNF214 MLXIPL TRIM28 BRD4 NCOA1 KMT2A ANO7 RERE BAG6 RGL4	2.08e-04	1062	180	22	int:FASN
Interaction	SOX17 interactions	SATB2 BCL9 ARID1A ATXN1L FOXP4 TRIM28	2.10e-04	95	180	6	int:SOX17
Interaction	MPHOSPH9 interactions	SPICE1 RNF214 LATS2 NUP155 AFDN DEUP1	2.10e-04	95	180	6	int:MPHOSPH9
Interaction	KLF3 interactions	SATB2 HIVEP1 KLF3 BCL11A RREB1 ARID1A ATXN1L FOXP4 KMT2A	2.17e-04	228	180	9	int:KLF3
Interaction	ANIB1 interactions	ESR1 NCOA1	2.37e-04	3	180	2	int:ANIB1
Interaction	LHX2 interactions	BCL9L SATB2 HIVEP1 RREB1 BCL9 ARID1A FOXP4 MRTFA	2.46e-04	183	180	8	int:LHX2
Interaction	RBPMS interactions	SMAP1 POU6F2 HIVEP1 VEZF1 PATZ1 MBNL1 RAD54L2 ATXN1L UNKL TENT2 SMAD3	2.51e-04	340	180	11	int:RBPMS
Interaction	SRF interactions	HIVEP1 MAPKAPK2 PHC3 FOXP4 NCOA1 MYOCD MRTFA	2.56e-04	139	180	7	int:SRF
Interaction	EMD interactions	DSG2 WFS1 USP9X GOLM2 SEC24A ESR1 NUP98 KLF3 PLXNB2 NUP35 LGALS9 AGO4 NUP155 ZNF341 TRIM28 BRD4 CEP70 NOTCH2	2.58e-04	789	180	18	int:EMD
Interaction	AIPL1 interactions	SMAP1 PATZ1 MTMR3 AIPL1	2.60e-04	35	180	4	int:AIPL1
Interaction	RBBP5 interactions	ESR1 KLF3 ARID1A KANSL2 TRIM28 BRD4 KMT2A RERE MED23 SMAD3	2.67e-04	287	180	10	int:RBBP5
Interaction	PHF21A interactions	RAPGEF6 HIVEP1 POLH ATG2B KLF3 RREB1 BIRC6 UBR5 BRD4 MRTFA KNL1	2.71e-04	343	180	11	int:PHF21A
Interaction	NUP205 interactions	NUP98 NUPR1 CEP164 NUP35 LGALS9 NUP155 TRIM28 BRD4 MTMR3	2.72e-04	235	180	9	int:NUP205
Interaction	PRR20E interactions	SMAP1 POU6F2 HIVEP1 VEZF1 PATZ1 GTF3C2	2.93e-04	101	180	6	int:PRR20E
Interaction	YWHAZ interactions	FOXO3 RAPGEF6 HIVEP1 SH2B3 RAPH1 MAP2 DSG2 MAPKAPK2 SEC24A ESR1 RBM26 PFAS SIK3 MLXIP ARID1A LGALS9 RIN1 MLXIPL LATS2 BRD4 MTMR3 MAP3K10 KMT2A AFDN CRTC2	2.94e-04	1319	180	25	int:YWHAZ
Interaction	CCNC interactions	POU6F2 IL37 ESR1 MED15 TP63 BRD4 MED12L MED23	2.95e-04	188	180	8	int:CCNC
Interaction	TLX3 interactions	BCL9L POU6F2 SATB2 HIVEP1 MAML1 BCL9 ARID1A ATXN1L FOXP4 RERE	2.98e-04	291	180	10	int:TLX3
Interaction	MSH3 interactions	KLF3 TSC22D2 TRIM29 NUPR1 TRIM28 BRD4	3.09e-04	102	180	6	int:MSH3
Interaction	SUPT5H interactions	HIVEP1 BICRA BCL11A ARID1A NUPR1 RNF214 SEC24C UBR5 BRD4 AIPL1 KMT2A MAML3	3.16e-04	408	180	12	int:SUPT5H
Interaction	NCOA6 interactions	ESR1 NUP35 MED15 NCOA1 KMT2A MED23 SMAD3	3.31e-04	145	180	7	int:NCOA6
Interaction	KDM3A interactions	GOLM2 STAT6 BRD4 MYOCD MRTFA	3.32e-04	67	180	5	int:KDM3A
Interaction	NCOA1 interactions	ESR1 BCL3 ARID1A STAT6 UBR5 NCOA1 SMAD3	3.45e-04	146	180	7	int:NCOA1
Interaction	RFXANK interactions	ARHGEF11 RIN1 FOXP4 TRIM28 ARHGEF1 BAG6 KNL1	3.45e-04	146	180	7	int:RFXANK
Interaction	SMAD1 interactions	FOXO3 USP9X ARID1A MED15 TOB1 GTF3C2 UNKL NOTCH2 SMAD3	3.47e-04	243	180	9	int:SMAD1
Interaction	NFAM1 interactions	BCL11A A2ML1 KMT2A	3.60e-04	16	180	3	int:NFAM1
Interaction	PLEK2 interactions	INPPL1 MUS81 TP63	3.60e-04	16	180	3	int:PLEK2
Interaction	VEZF1 interactions	POU6F2 HIVEP1 VEZF1 ESR1 TRIM28 NOTCH2	3.62e-04	105	180	6	int:VEZF1
Interaction	CIC interactions	SATB2 ESR1 KLF3 RAD54L2 RREB1 ATXN1L NUP35 MLXIPL NUP155 SEC24C GTF3C2 BAZ2A LMX1B TRIM28 PAX3 SMAD3	3.66e-04	673	180	16	int:CIC
Cytoband	11q23.3	BCL9L SIK3 TRIM29 CEP164 RNF214	1.63e-05	78	184	5	11q23.3
Cytoband	Ensembl 112 genes in cytogenetic band chr11q23	BCL9L SIK3 TRIM29 CEP164 RNF214 KMT2A ARHGAP20	3.25e-05	220	184	7	chr11q23
GeneFamily	Forkhead boxes	FOXJ2 FOXO3 FOXN1 FOXP4	2.39e-04	43	128	4	508
GeneFamily	PHD finger proteins	TCF19 BAZ2A TRIM28 KMT2A KAT6B	4.47e-04	90	128	5	88
GeneFamily	Granins	VGF GNAS	1.35e-03	8	128	2	925
GeneFamily	Nucleoporins	NUP98 NUP35 NUP155	1.48e-03	32	128	3	1051
GeneFamily	Cyclins\|Mediator complex	MED15 MED12L MED23	1.62e-03	33	128	3	1061
GeneFamily	CUT class homeoboxes and pseudogenes	SATB2 ONECUT3	1.73e-03	9	128	2	527
GeneFamily	Zinc fingers CCCH-type	MBNL1 RBM26 UNKL	1.92e-03	35	128	3	73
GeneFamily	N-BAR domain containing	AMPH ARHGAP17	3.13e-03	12	128	2	1289
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	FOXO3 PATZ1 NUP98 ETV1 BCL11A BCL3 BCL9 BRD4 KMT2A AFDN PAX3 GNAS KAT6B KNL1	7.06e-08	323	183	14	M9150
Coexpression	GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN	BCL9L SMARCAL1 MAML1 MLXIP ARID1A PLXNB2 KMT2A ARRDC2 MRTFA SMAD3	1.54e-06	200	183	10	M5851
Coexpression	GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	RAPGEF6 HIVEP1 SH2B3 VEZF1 ATXN1L SCYL2 KANSL2 MTMR3 TRMT12	1.07e-05	197	183	9	M4237
Coexpression	GSE13306_TREG_VS_TCONV_UP	BCL9L RAPGEF6 RAD54L2 PLA2G4E NUPR1 CACNA2D4 GTF3C2 SLC45A2 TRMT12	1.12e-05	198	183	9	M3229
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	FOXO3 AMPH SATB2 HIVEP1 VEZF1 USP9X SEC24A MBNL1 NUP98 SIK3 TSC22D2 GTF3C2 UBR5 MTMR3 NCOA1 KAT6B MRTFA SMAD3	3.35e-05	856	183	18	M4500
Coexpression	GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP	ETV1 RHBDL1 MLXIP RIN1 SLC45A2 LRRC8B SMAD3	4.49e-05	134	183	7	M430
Coexpression	ZHENG_BOUND_BY_FOXP3	AMPH RAPGEF6 MBNL1 KLF3 NFKBIZ ST6GAL1 SIK3 USF3 LATS2 KAT6B MRTFA SMAD3 KNL1	5.15e-05	498	183	13	M1741
Coexpression	ZHENG_BOUND_BY_FOXP3	AMPH RAPGEF6 MBNL1 KLF3 NFKBIZ ST6GAL1 SIK3 USF3 LATS2 KAT6B MRTFA SMAD3 KNL1	6.17e-05	507	183	13	MM1030
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP	FOXO3 BCL9L MAPKAPK2 KLF3 TSC22D2 MLXIP USF3 CRTC2	6.42e-05	192	183	8	M8272
Coexpression	GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN	FOXO3 VEZF1 KLF3 ST6GAL1 SIK3 TSC22D2 UNKL ARRDC2	7.16e-05	195	183	8	M7310
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	FOXO3 MBNL1 MAML1 ST6GAL1 SIK3 RIN1 CATSPERB KAT6B	7.42e-05	196	183	8	M5381
Coexpression	GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN	BCL9L SMARCAL1 BCL3 MLXIP PLXNB2 ARRDC2 MRTFA SMAD3	7.69e-05	197	183	8	M5853
Coexpression	GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN	SMARCAL1 MLXIP ARID1A PLXNB2 KMT2A ARRDC2 MRTFA SMAD3	7.69e-05	197	183	8	M5877
Coexpression	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	MUS81 GRHL2 MSTO1 UBR5 USP32 MTMR3 RERE MED23	8.25e-05	199	183	8	M7530
Coexpression	GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	WFS1 BCAS3 STAT6 SPICE1 USF3 LATS2 BAZ2A UNKL	8.54e-05	200	183	8	M5995
Coexpression	GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP	GOLM2 BCL11A TENM2 CEP164 TOB1 BAZ2A UNKL NOTCH2	8.54e-05	200	183	8	M7500
Coexpression	GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP	BCL9L KLF3 STAT6 CACNA2D4 TOB1 RERE MRTFA SMAD3	8.54e-05	200	183	8	M5046
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN	FOXO3 MAPKAPK2 BICRA NUP98 KLF3 BCL3 IRGQ SIK3 ATXN1L PHC3 KANSL2 USF3 BAZ2A MTMR3 NCOA1 LRRC8B MED23	9.44e-05	844	183	17	M41129
Coexpression	TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING	WFS1 RBM26 NFKBIZ NUPR1 MLXIPL FOXP4 ZFHX2 NCOA1	1.28e-04	212	183	8	MM3816
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	SATB2 MAP2 DSG2 USP9X GOLM2 ESR1 ETV1 BCL11A BCL9 TRIM29 TENM2 AGO4 LATS2 NUP155 GLI2 TP63 SPRY4 PAX3 RIMS1 KAT6B	9.68e-06	769	181	20	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	SATB2 MAP2 PRR36 DSG2 MAPKAPK2 RBM26 ETV1 NFKBIZ BCL11A BCL3 BCL9 ARID1A GRHL2 LGALS9 MLXIPL TP63 CEP83 CEP70 CFAP74 MAML3 TENT2 KNL1	3.80e-05	989	181	22	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#2	POU6F2 ASAP3 ADGRB2 BCL3 LGALS4 LGALS9 SERPINA11 CSPG4 ARHGAP20	5.05e-05	197	181	9	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	SMAP1 POU6F2 MBNL1 SERPINA11 RNF214 USF3 ARHGEF1 CEP70 CFAP74 ONECUT3 MAML3 TRMT12	6.26e-05	359	181	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500	SATB2 MAP2 PRR36 DSG2 ETV1 NFKBIZ BCL11A BCL3 BCL9 GRHL2 LGALS9 MLXIPL TP63 CEP70	8.72e-05	492	181	14	Facebase_RNAseq_e10.5_Maxillary Arch_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000	SMAP1 POU6F2 SATB2 PRR36 ASAP3 BCL11A BCL3 BCL9 ARID1A NUPR1 LGALS4 LGALS9 SERPINA11 MLXIPL TP63 CEP83 CEP70 NCOA1 CFAP74 MAML3 DEUP1	9.64e-05	979	181	21	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	ABI3BP MAP2 PRR36 DSG2 MAPKAPK2 DTNA POLH ADGRB2 BCL11A BCL3 GRHL2 TENM2 LGALS9 MLXIPL TP63 CSPG4 MED12L ZFHX2 NCOA1 LRRC8B ARHGAP20	1.03e-04	984	181	21	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	AMPH VEZF1 MAP2 PRR36 DTNA RBM26 ETV1 ARHGAP17 BCL11A IRGQ SIK3 BCL9 ARID1A PKNOX2 MLXIPL FOXP4 BRD4 USP32 CEP83 ZFHX2 PACC1 LRRC8B RIMS1 RERE DEUP1 KNL1	1.03e-04	1370	181	26	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4	SATB2 ABI3BP RAPH1 ASAP3 ADGRB2 ETV1 BCL3 BCL9 LGALS4 LGALS9 CSPG4 CEP70 CFAP74 PAX3 ARHGAP20 TENT2	1.61e-04	655	181	16	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FOXO3 BCAS3 MBNL1 NUP98 SIK3 BIRC6 RERE MAML3 MRTFA	1.17e-07	193	184	9	779276e775cb2492e8dd36436295a536084a6415
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP9X BCL9 ARID1A BIRC6 USF3 BAZ2A USP32 LRRC8B MED23	1.17e-07	193	184	9	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	ASAP3 ARID1A ARHGEF10L MLXIPL AGO4 CEP70 MED12L NOTCH2	3.88e-07	162	184	8	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	facs\|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BICRA RBM26 PFAS MLXIP BIRC6 LGALS9 KANSL2 NOTCH2	5.85e-07	171	184	8	c9990bc041a632b2f7bbebbfe737772c423d7027
ToppCell	TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6\|TCGA-Skin / Sample_Type by Project: Shred V9	FOXN1 PLA2G4E TRIM29 GRHL2 TENM2 CLCA2 TP63 A2ML1	1.15e-06	187	184	8	2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f
ToppCell	Skin\|World / Skin and Kidney Cells in Lupus Nephritis Patients.	FOXN1 KLF3 BCL11A PLA2G4E TRIM29 NUPR1 CLCA2 TP63	1.83e-06	199	184	8	6be1340413ee868c610b6e3f58c65b493eb22bb5
ToppCell	Ionocyte-iono-1\|World / Class top	EPHX2 DTNA NUPR1 SOCS7 CSPG4 GNAS CKAP2	6.73e-06	169	184	7	4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c
ToppCell	TCGA-Head_and_Esophagus\|World / Sample_Type by Project: Shred V9	FOXN1 PLA2G4E TRIM29 TENM2 CLCA2 TP63 A2ML1	7.55e-06	172	184	7	eb18aa179db1818f408c38e442ecfed8582d7dbc
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DCHS2 POU6F2 ABI3BP MAP2 PKNOX2 GLI2 TP63	9.80e-06	179	184	7	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 POU6F2 MAP2 DTNA F5 PKNOX2 TP63	1.05e-05	181	184	7	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 POU6F2 MAP2 DTNA F5 PKNOX2 TP63	1.05e-05	181	184	7	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP1 USP9X ESR1 NFKBIZ TSC22D2 MLXIP TRIM29	1.21e-05	185	184	7	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL9L MAPKAPK2 MTSS1 BCL3 TRIM29 TENM2 FOXP4	1.26e-05	186	184	7	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BICRA KLF3 TRIM29 SOCS7 LATS2 PAX3 TRMT12	1.30e-05	187	184	7	a6a112689d1c9049f57935ad9d2f4955538427de
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	POU6F2 MAP2 ADGRB2 F5 PKNOX2 TP63 MAML3	1.35e-05	188	184	7	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	POU6F2 MAP2 ADGRB2 F5 PKNOX2 TP63 MAML3	1.35e-05	188	184	7	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	MAP2 DTNA MBNL1 ARHGEF10L MYOCD PAX3 RIMS1	1.39e-05	189	184	7	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP DTNA GLI2 MYOCD ARHGAP20 NOTCH2 SMAD3	1.49e-05	191	184	7	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	facs-Tongue-nan-3m-Epithelial-keratinocyte\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXN1 MAP2 PLA2G4E ARHGEF10L CLCA2 AFDN NOTCH2	1.60e-05	193	184	7	33437fdb417d78463caee14a9f0e094da1733829
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FOXO3 ABI3BP NFKBIZ NCOA1 CATSPERB MRTFA SMAD3	1.71e-05	195	184	7	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	5'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SATB2 DSG2 MLXIP NUPR1 ARHGEF10L LGALS4 LGALS9	1.88e-05	198	184	7	08982f9e37591261975ddff9b9a6a59ba836fc0f
ToppCell	5'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SATB2 DSG2 MLXIP NUPR1 ARHGEF10L LGALS4 LGALS9	1.88e-05	198	184	7	45a1287dc618a37949978b297e2b782ea80a7f39
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	BCAS3 SIK3 BIRC6 UBR5 NCOA1 RERE MAML3	1.94e-05	199	184	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	USP9X GOLM2 RBM26 MAML1 ARID1A KMT2A NOTCH2	1.94e-05	199	184	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Kidney-Keratinocytes\|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.	FOXN1 USP9Y TRIM29 CLCA2 TP63 A2ML1 RGL4	2.01e-05	200	184	7	41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	CACNA1E RAPH1 MAP2 MTSS1 BCL11A TENM2 FOXP4	2.01e-05	200	184	7	f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b
ToppCell	pdx-Tumor_cells-T9\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 MAPKAPK2 SIK3 SCYL2 LATS2 MRTFA	3.01e-05	144	184	6	0b94d978262a826c9254145aa98c6c30240243f9
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KLF3 BCL9 ARHGEF10L TRIM28 A2ML1 AFDN	3.65e-05	149	184	6	c773c2b9685ec44a35246180a93456c8765353f5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	POU6F2 DTNA ADGRB2 F5 TENM2 EXOC3L4	5.06e-05	158	184	6	e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	POU6F2 DTNA ADGRB2 F5 TENM2 EXOC3L4	5.06e-05	158	184	6	d39e020c3e77eb9d3de600a171d22f94357061d4
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GAL1 BCL11A SPICE1 USF3 ZNF341 MED12L	5.81e-05	162	184	6	e81dec1db8e5a808d96e58410c91961e5d065c94
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GAL1 BCL11A SPICE1 USF3 ZNF341 MED12L	5.81e-05	162	184	6	d19b469f64c9064cfb82dadb6c8135e28949a02a
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ST6GAL1 BCL11A SPICE1 USF3 ZNF341 MED12L	5.81e-05	162	184	6	10c2aa047f33f48e4abe676236bbdb593079dd1d
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INPPL1 POLH NUPR1 EXOC3L4 SLC45A2 ZSWIM4	6.22e-05	164	184	6	b77995958c938e10a526118f75d78cee72e0b207
ToppCell	wk_20-22-Hematologic-Myeloid-GMP\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SIK3 RREB1 SHPK BRD4 KNL1 RGL4	6.65e-05	166	184	6	d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FOXN1 SATB2 PRR36 ETV1 F5 ONECUT3	7.59e-05	170	184	6	02f0be0aab8ba2d35a83238609352ef3677511c9
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AMPH DTNA TENM2 ARHGEF10L MYOCD NOTCH2	7.84e-05	171	184	6	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E MAP2 ARHGAP17 BCL11A RIN1 KANSL2	8.36e-05	173	184	6	1b9b4e165121b08ef15a93fca6bea875cae69f19
ToppCell	droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E MAP2 ARHGAP17 BCL11A RIN1 KANSL2	8.36e-05	173	184	6	c25f24d7b672c9686d31ebc8d263042282f520fd
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ASAP3 PFAS TRIM29 RIMS1 ZSWIM4	8.59e-05	108	184	5	9c7f3e25facfb54ef0be45044999bc36438bbea0
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ASAP3 PFAS TRIM29 RIMS1 ZSWIM4	8.59e-05	108	184	5	75d635fc5bb004418db2e1328c24d96b718f10b1
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SOCS7 CLCA2 GLI2 NCOA1 RIMS1 SMAD3	8.63e-05	174	184	6	42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FOXN1 PRR36 ETV1 TRIM29 F5 ONECUT3	9.19e-05	176	184	6	2e1003dc373b14d27f0464d980453fdcfc1005f0
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs\|normal_Pleural_Fluid / Location, Cell class and cell subclass	PLXNB2 NUPR1 SPICE1 RIN1 KANSL2 SHPK	9.19e-05	176	184	6	7a74217b7fa1032b918f00a3972dff5fab74671a
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGF POU6F2 ASAP3 ETV1 TOB1 GNAS	9.48e-05	177	184	6	1dc69c661e70e7e22bd9d7cf953eb638da9fd43c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGF POU6F2 ASAP3 ETV1 TOB1 GNAS	9.48e-05	177	184	6	426a9845df7fd13b02e744532c336c60bc4d4a22
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAPH1 NUPR1 NUP155 CSPG4 MAP3K10 MAML3	1.01e-04	179	184	6	f99500c4a590e5152ded5862690f7fa614d64a80
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAPH1 NUPR1 NUP155 CSPG4 MAP3K10 MAML3	1.01e-04	179	184	6	7d61466181ab73088de3ec8a129d7cfa8cac7ecc
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAPH1 NUPR1 NUP155 CSPG4 MAP3K10 MAML3	1.01e-04	179	184	6	6c98ce32cb55cf9cee557449e41b23bdb22f5efd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	POU6F2 MAP2 F5 TENM2 LMX1B MAML3	1.14e-04	183	184	6	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3\|TCGA-Lung / Sample_Type by Project: Shred V9	FOXN1 BCL11A TRIM29 TENM2 GLI2 TP63	1.17e-04	184	184	6	ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCell	Posterior_cortex-Neuronal-Excitatory\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CACNA1E SATB2 ADGRB2 BCL11A TENM2 RIN1	1.17e-04	184	184	6	25ccf08a8a26d7e7827b6357f33a53aaf423577d
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	INPPL1 ATG2B F5 BAHD1 MED23	1.20e-04	116	184	5	f2bf9599040f43b5ea8724841d7b71c0a859c016
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP UBR5 KMT2A MYOCD NOTCH2 SMAD3	1.32e-04	188	184	6	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP UBR5 KMT2A MYOCD NOTCH2 SMAD3	1.32e-04	188	184	6	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP UBR5 KMT2A MYOCD NOTCH2 SMAD3	1.32e-04	188	184	6	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBM26 NFKBIZ TENM2 MLXIPL ZFHX2 NCOA1	1.32e-04	188	184	6	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPKAPK2 MTSS1 BCL3 TRIM29 TENM2 FOXP4	1.36e-04	189	184	6	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP DTNA GLI2 MYOCD NOTCH2 SMAD3	1.36e-04	189	184	6	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	FOXN1 PLA2G4E TRIM29 CLCA2 TP63 A2ML1	1.40e-04	190	184	6	3188c7bd225cbcf46a21e2fb784336cdd9665995
ToppCell	TCGA-Skin-Primary_Tumor\|TCGA-Skin / Sample_Type by Project: Shred V9	FOXN1 PLA2G4E TRIM29 CLCA2 TP63 A2ML1	1.40e-04	190	184	6	e2b26a03c6ab24d9b0f4150c47597be37767d86e
ToppCell	TCGA-Skin-Primary_Tumor-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	FOXN1 PLA2G4E TRIM29 CLCA2 TP63 A2ML1	1.40e-04	190	184	6	01fb45add4661bc86cd0a34fac35177907152dbb
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSG2 TRIM29 CLCA2 TP63 CKAP2 KNL1	1.44e-04	191	184	6	0f9443da0f73d07456142fae08b2dc92a5b7b592
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-leukocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POU6F2 DSG2 TRIM29 GRHL2 FOXP4 TP63	1.44e-04	191	184	6	116fba9badea093e11f370996247cca0e4c02e8f
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL11A TRIM29 TENM2 TP63 CSPG4 AFDN	1.44e-04	191	184	6	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WFS1 RBM26 NFKBIZ MLXIPL ZFHX2 NCOA1	1.44e-04	191	184	6	3387b95a3f2445c672d407922fdce3a91eabaef8
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP DTNA BCL11A GLI2 MYOCD SMAD3	1.44e-04	191	184	6	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NUP98 NFKBIZ SIK3 TSC22D2 LATS2 ARHGAP20	1.48e-04	192	184	6	6bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 PPRC1 DTNA NFKBIZ MRTFA SMAD3	1.48e-04	192	184	6	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SMAP1 RAPH1 ZPLD1 NFKBIZ MRTFA SMAD3	1.48e-04	192	184	6	2510f22197502f60fd266b7f42eff040f25b8ae7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SMAP1 RAPH1 ZPLD1 NFKBIZ MRTFA SMAD3	1.48e-04	192	184	6	e8e316f396834bcd34843e56e1d86f310fd6aada
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-goblet\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GRHL2 ARHGEF10L LGALS4 FOXP4 CLCA2 ANO7	1.52e-04	193	184	6	402aad2f9e789ad1f2e1536cdc9ce61de7625427
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PPRC1 NUP98 NFKBIZ SIK3 LATS2 MRTFA	1.52e-04	193	184	6	dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	ABI3BP TENM2 PKNOX2 GLI2 EXOC3L4 MOCS1	1.52e-04	193	184	6	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GRHL2 ARHGEF10L LGALS4 FOXP4 CLCA2 ANO7	1.52e-04	193	184	6	7ee3b1ef5c455f321b4e154ae62c69543fe9b30e
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 MBNL1 UBR5 AFDN RERE TENT2	1.52e-04	193	184	6	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	CV-Severe-6\|Severe / Virus stimulation, Condition and Cluster	MTSS1 NFKBIZ COX17 TOB1 NCOA1 KMT2A	1.56e-04	194	184	6	d33be6ed1de907aeea0c2dce09796556b8efdd4e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MTSS1 ST6GAL1 BCL11A SIK3 RERE KNL1	1.61e-04	195	184	6	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MTSS1 ST6GAL1 BCL11A SIK3 RERE KNL1	1.61e-04	195	184	6	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BCL11A TRIM29 TENM2 LGALS4 TP63 MED12L	1.61e-04	195	184	6	6c9c58322c1df891bb4bab56dacb542c8777bb7d
ToppCell	control-immature_Neutrophil\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF19 IRGQ ARHGEF11 PHC3 MAML3 MRTFA	1.65e-04	196	184	6	e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	AMPH PPRC1 BCAS3 RHBDL1 PLXNB2 SMAD3	1.70e-04	197	184	6	6b6504c47c309bac4f790e2f372d454bbdea49e8
ToppCell	Healthy_donor-Non-classical_Monocyte\|Healthy_donor / disease group, cell group and cell class (v2)	SH2B3 MTSS1 NFKBIZ PLXNB2 LGALS9 RIN1	1.75e-04	198	184	6	d4eae333fa100db3ea2d4cbe7a1d6ab14816f0e2
ToppCell	Sigmoid-B_cell-Follicular_B_cell\|B_cell / Region, Cell class and subclass	MTSS1 KLF3 BCL11A LGALS9 ARRDC2 SMAD3	1.79e-04	199	184	6	2141ab1d4d0885fbed8f76b3994f49b787cb8dd3
ToppCell	Transverse-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	RAPGEF6 RAPH1 ARHGEF10L MLXIPL GTF3C2 UNKL	1.79e-04	199	184	6	fd75dccb37d96448edf72b7d042b06833d4ead24
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	AMPH TENM2 PKNOX2 CSPG4 SPRY4 MYOCD	1.84e-04	200	184	6	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	severe-cDC\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SH2B3 DTNA BCL11A PLXNB2 LGALS9 MAML3	1.84e-04	200	184	6	26e04ea276dbca5cde48335c401269c7123b54d2
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	PLXNB2 PKNOX2 CSPG4 SPRY4 LRRC8B NOTCH2	1.84e-04	200	184	6	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
Drug	Iodipamide [606-17-7]; Up 200; 3.6uM; MCF7; HT_HG-U133A	DTNA ESR1 ST6GAL1 BCL11A TSC22D2 RAD54L2 TRIM29 ARHGEF11 STAT6 PKNOX2 BAZ2A AIPL1	5.91e-08	196	181	12	5510_UP
Drug	Nialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A	ESR1 MTSS1 ASAP3 ADGRB2 TRIM29 F5 PKNOX2 PHC3 BAZ2A ZFHX2 AFDN MRTFA	6.61e-08	198	181	12	4525_UP
Drug	Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ABI3BP ASAP3 ADGRB2 RHBDL1 ST6GAL1 NUPR1 PHC3 BAZ2A TP63 CATSPERB MRTFA	6.24e-07	200	181	11	2224_UP
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	FOXJ2 SATB2 PPRC1 ESR1 BCL3 MLXIP ARID1A RERE KAT6B SMAD3	3.19e-06	191	181	10	1057_DN
Drug	Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	DTNA ESR1 ASAP3 POM121L2 RAD54L2 TRIM29 LGALS4 PKNOX2 PHC3 BAZ2A	3.66e-06	194	181	10	4828_UP
Drug	Droperidol [548-73-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	SATB2 ASAP3 ADGRB2 KLF3 BCL3 PHC3 AGO4 BAZ2A BRD4 NOTCH2	4.01e-06	196	181	10	4629_DN
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A	DCHS2 DTNA SEC24A MLXIP TRIM29 LGALS4 PKNOX2 TP63 ZFHX2 MRTFA	4.01e-06	196	181	10	2250_UP
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	MAPKAPK2 BCL3 IRGQ BCL9 MED15 BAZ2A TRIM28 SHPK BRD4 SMAD3	4.20e-06	197	181	10	3415_DN
Drug	Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; PC3; HT_HG-U133A	AMPH DTNA ESR1 ETV1 CEP164 PKNOX2 CLCA2 BAZ2A TP63 CSPG4	4.20e-06	197	181	10	4199_UP
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	PRR36 MAPKAPK2 RAD54L2 BCL9 F5 SOCS7 BAZ2A BRD4 UNKL RERE	4.20e-06	197	181	10	2766_UP
Drug	Oxaprozin [21256-18-8]; Up 200; 13.6uM; PC3; HT_HG-U133A	PRR36 ESR1 RBM26 ADGRB2 ETV1 TRIM29 MTMR3 AIPL1 PACC1 RERE	4.39e-06	198	181	10	4530_UP
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	VGF EPHX2 PRR36 DTNA POLH BCL3 TRIM29 FGF23 MTMR3 NCOA1	4.39e-06	198	181	10	4351_DN
Drug	Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A	PRR36 DTNA ESR1 BCL3 ARHGEF11 NUPR1 PHC3 CLCA2 GNAS SMAD3	4.39e-06	198	181	10	4812_UP
Drug	Piperine [94-62-2]; Up 200; 14uM; PC3; HT_HG-U133A	MAP2 ETV1 TSC22D2 MLXIP TRIM29 F5 PHC3 BAZ2A PACC1 PAX3	4.59e-06	199	181	10	4247_UP
Drug	fullerene C60	FOXO3 FOXN1 CACNA1E SATB2 HIVEP1 PPRC1 BCAS3 PATZ1 SEC24A INPPL1 MTSS1 NUP98 NFKBIZ PFAS ST6GAL1 ARHGEF11 PLXNB2 CEP164 LATS2 BAZ2A TRIM28 SPRY4 USP32 MAP3K10 LRRC8B ARRDC2 MOCS1 NOTCH2 CRTC2	7.47e-06	1498	181	29	ctd:C069837
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	HIVEP1 PATZ1 ESR1 KLF3 BCL3 ARID1A ARHGEF1 KAT6B SMAD3	7.54e-06	166	181	9	2247_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	HIVEP1 PPRC1 PATZ1 ESR1 BCL3 ARID1A GTF3C2 KAT6B SMAD3	1.00e-05	172	181	9	3428_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	PPRC1 PATZ1 ESR1 BCL3 RREB1 ARID1A UNKL KAT6B SMAD3	1.00e-05	172	181	9	1072_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	HIVEP1 PPRC1 PATZ1 ESR1 KLF3 BCL3 ARID1A KAT6B SMAD3	1.00e-05	172	181	9	5903_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	PPRC1 PATZ1 ESR1 INPPL1 BCL3 ARID1A GTF3C2 UNKL KAT6B	1.32e-05	178	181	9	1112_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PPRC1 PATZ1 ESR1 BCL3 ARID1A MED15 GTF3C2 KAT6B SMAD3	1.45e-05	180	181	9	4821_DN
Drug	Asbestos, Crocidolite	VGF FOXO3 RAPGEF6 HIVEP1 MAPKAPK2 SEC24A MAML1 NFKBIZ BCL3 SIK3 TSC22D2 RREB1 ARID1A ARHGEF11 PHC3 KANSL2 LATS2 TP63 SPRY4 MAP3K10 NCOA1 MYOCD ZSWIM4 MAML3 NOTCH2	1.77e-05	1241	181	25	ctd:D017638
Drug	C75; Down 200; 10uM; PC3; HT_HG-U133A	VGF EPHX2 ASAP3 KLF3 TSC22D2 STAT6 CSPG4 ZFHX2 NOTCH2	2.32e-05	191	181	9	6399_DN
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A	DTNA ESR1 TSC22D2 ARID1A TRIM29 PHC3 MTMR3 GNAS MRTFA	2.41e-05	192	181	9	3400_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	VGF PRR36 RAD54L2 F5 RIN1 BAZ2A TP63 RERE MRTFA	2.62e-05	194	181	9	3969_DN
Drug	Tropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A	SH2B3 MAPKAPK2 PATZ1 ESR1 KLF3 FGF23 GTF3C2 RERE SMAD3	2.62e-05	194	181	9	3619_DN
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	DTNA ESR1 ASAP3 TRIM29 SCYL2 GTF3C2 KMT2A KAT6B MOCS1	2.62e-05	194	181	9	3840_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	VGF MAML1 MLXIP RIN1 CLCA2 LRRC8B MAGEC1 KAT6B MRTFA	2.62e-05	194	181	9	2223_UP
Drug	Loracarbef [121961-22-6]; Up 200; 10.8uM; PC3; HT_HG-U133A	DCHS2 AMPH ESR1 MTSS1 LGALS4 AGO4 AIPL1 SLC45A2 PAX3	2.73e-05	195	181	9	5073_UP
Drug	Loracarbef [121961-22-6]; Up 200; 10.8uM; HL60; HT_HG-U133A	ARID1A TRIM29 ARHGEF11 BAHD1 CEP164 MLXIPL AFDN SMAD3 TRMT12	2.73e-05	195	181	9	2970_UP
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	PRR36 MAPKAPK2 DTNA MAML1 BCL3 RAD54L2 CEP164 MED15 ARHGEF1	2.73e-05	195	181	9	3923_DN
Drug	Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A	ESR1 MTSS1 MLXIP TRIM29 F5 AGO4 BAZ2A TP63 SLC45A2	2.84e-05	196	181	9	2310_UP
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	DTNA BICRA ATG2B TSC22D2 BCL9 STAT6 BRD4 NCOA1 SMAD3	2.84e-05	196	181	9	3422_DN
Drug	Edrophonium chloride [116-38-1]; Up 200; 19.8uM; PC3; HT_HG-U133A	DCHS2 ESR1 F5 BAZ2A GLI2 AFDN SLC45A2 PAX3 MRTFA	2.84e-05	196	181	9	6655_UP
Drug	Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; PC3; HT_HG-U133A	ESR1 RAD54L2 ARID1A F5 RIN1 ARHGEF1 TP63 PACC1 MOCS1	2.96e-05	197	181	9	6350_UP
Drug	2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A	DTNA RBM26 ETV1 BCL3 PKNOX2 GLI2 TTC21B UNKL SLC45A2	2.96e-05	197	181	9	4433_UP
Drug	Colistin sulfate [1264-72-8]; Up 200; 3uM; MCF7; HT_HG-U133A	EPHX2 IL37 PATZ1 MBNL1 MLXIP BAHD1 SCYL2 ZFHX2 NOTCH2	2.96e-05	197	181	9	4796_UP
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	EPHX2 POLH ASAP3 BCL3 PLXNB2 CEP164 MED15 GNAS MRTFA	2.96e-05	197	181	9	3885_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; PC3; HT_HG-U133A	VGF BCAS3 DTNA ESR1 ST6GAL1 BCL3 TSC22D2 F5 RIN1	2.96e-05	197	181	9	4189_DN
Drug	Tranexamic acid [1197-18-8]; Up 200; 25.4uM; MCF7; HT_HG-U133A	MTSS1 ASAP3 ADGRB2 ST6GAL1 BCL11A TRIM29 SLC45A2 PACC1 MRTFA	2.96e-05	197	181	9	2248_UP
Drug	Phensuximide [86-34-0]; Down 200; 21.2uM; PC3; HT_HG-U133A	BCAS3 POLH ADGRB2 ETV1 BCL11A ARHGEF1 GNAS NOTCH2 SMAD3	2.96e-05	197	181	9	5097_DN
Drug	Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; PC3; HT_HG-U133A	DTNA RBM26 POM121L2 PKNOX2 MLXIPL TP63 ZFHX2 PACC1 SYNGR4	3.07e-05	198	181	9	4071_UP
Drug	Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A	ESR1 POLH NUP98 KLF3 BCL9 BAHD1 BAZ2A BRD4 SMAD3	3.07e-05	198	181	9	1690_DN
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A	PRR36 ESR1 ST6GAL1 F5 CEP164 PKNOX2 BAZ2A TP63 AIPL1	3.07e-05	198	181	9	5520_UP
Drug	Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A	TSC22D2 USP9Y SOCS7 LGALS4 PKNOX2 MLXIPL TP63 KMT2A SMAD3	3.07e-05	198	181	9	2273_UP
Drug	Bisoprolol fumarate; Down 200; 9uM; HL60; HT_HG-U133A	IRGQ RAD54L2 MLXIP ARHGEF10L BAZ2A TRIM28 ARHGEF1 NCOA1 KMT2A	3.07e-05	198	181	9	1287_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A	EPHX2 MAP2 DTNA BCL3 PKNOX2 BAZ2A ARHGEF1 UNKL MRTFA	3.20e-05	199	181	9	4986_UP
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	VGF HIVEP1 DTNA POLH MTSS1 TSC22D2 MLXIP MED15 KMT2A	3.20e-05	199	181	9	7192_DN
Drug	Azaperone [1649-18-9]; Up 200; 12.2uM; HL60; HT_HG-U133A	ESR1 ETV1 BCL3 ARHGEF11 SOCS7 PKNOX2 CLCA2 CFAP74 RERE	3.20e-05	199	181	9	6151_UP
Drug	Flutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A	VGF ETV1 TSC22D2 MLXIP CSPG4 NCOA1 CATSPERB PACC1 RERE	3.20e-05	199	181	9	4539_UP
Drug	clofibrate; Up 200; 100uM; MCF7; HG-U133A	DTNA BICRA ESR1 POM121L2 BAHD1 ARHGEF10L CFAP74 SLC45A2 GNAS	3.20e-05	199	181	9	444_UP
Drug	Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; HL60; HT_HG-U133A	ESR1 POLH MBNL1 ARHGEF11 F5 SHPK ZFHX2 PACC1 RERE	3.33e-05	200	181	9	2905_DN
Drug	Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A	EPHX2 MAP2 ASAP3 TSC22D2 KMT2A AFDN LRRC8B NOTCH2 MRTFA	3.33e-05	200	181	9	6005_UP
Drug	Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; HL60; HT_HG-U133A	BCAS3 MAPKAPK2 TRIM29 ARHGEF11 SOCS7 PHC3 CFAP74 SMAD3 SYNGR4	3.33e-05	200	181	9	2169_UP
Drug	Clidinium bromide [3485-62-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A	EPHX2 PRR36 DTNA POM121L2 TRIM29 CEP164 STAT6 ARHGEF1 TP63	3.33e-05	200	181	9	6837_UP
Drug	estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A	PPRC1 DTNA ESR1 ASAP3 POM121L2 TSC22D2 TP63 KMT2A MED23	3.33e-05	200	181	9	665_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	PPRC1 PATZ1 ESR1 KLF3 BCL3 ARID1A KAT6B SMAD3	4.98e-05	163	181	8	5594_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	HIVEP1 PPRC1 PATZ1 ESR1 BCL3 ARID1A KAT6B SMAD3	5.42e-05	165	181	8	2835_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	HIVEP1 PPRC1 PATZ1 ESR1 BCL3 ARID1A UNKL KAT6B	5.66e-05	166	181	8	7324_DN
Drug	2-nitropyrene	SLC45A2 CKAP2	6.29e-05	2	181	2	CID000013090
Drug	Pcb-155	ESR1 LGALS4	6.29e-05	2	181	2	CID003080840
Drug	HO-PCB 104	ESR1 LGALS4	6.29e-05	2	181	2	CID000177870
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PPRC1 PATZ1 ESR1 BCL3 ARID1A UNKL KAT6B SMAD3	6.69e-05	170	181	8	5260_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	PPRC1 PATZ1 ESR1 BCL3 ARID1A GTF3C2 KAT6B SMAD3	6.69e-05	170	181	8	1050_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	HIVEP1 PPRC1 PATZ1 ESR1 BCL3 RREB1 ARID1A KAT6B	6.98e-05	171	181	8	1000_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PPRC1 PATZ1 ESR1 BCL3 ARID1A GTF3C2 UNKL KAT6B	7.57e-05	173	181	8	3243_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	HIVEP1 PATZ1 ESR1 ARID1A GTF3C2 UNKL KAT6B SMAD3	7.57e-05	173	181	8	5336_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	HIVEP1 PATZ1 ESR1 BCL3 ARID1A ARHGEF10L KAT6B SMAD3	7.88e-05	174	181	8	3462_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	HIVEP1 PPRC1 PATZ1 ESR1 BCL3 ARID1A KAT6B SMAD3	7.88e-05	174	181	8	5945_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PPRC1 PATZ1 ESR1 ARID1A PLXNB2 UNKL KAT6B SMAD3	7.88e-05	174	181	8	5693_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	HIVEP1 PPRC1 PATZ1 ESR1 BCL3 ARID1A KAT6B SMAD3	8.20e-05	175	181	8	1014_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	PATZ1 ESR1 BCL3 RREB1 ARID1A SHPK KAT6B SMAD3	8.20e-05	175	181	8	1058_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PPRC1 PATZ1 ESR1 BCL3 ARID1A BRD4 KAT6B SMAD3	8.54e-05	176	181	8	6784_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	HIVEP1 PATZ1 ESR1 BCL3 ARID1A PLXNB2 KAT6B SMAD3	8.54e-05	176	181	8	5976_DN
Drug	Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; PC3; HT_HG-U133A	ESR1 MTSS1 BCL3 TRIM29 NUPR1 F5 BAZ2A SLC45A2	9.60e-05	179	181	8	4085_UP
Drug	lomustine; Down 200; 100uM; PC3; HT_HG-U133A	ABI3BP PATZ1 MTSS1 ETV1 ST6GAL1 BCL3 TSC22D2 GRHL2	9.98e-05	180	181	8	7094_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PPRC1 PATZ1 ESR1 BCL3 ARID1A PHC3 GTF3C2 KAT6B	1.12e-04	183	181	8	3510_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	SMARCAL1 BCL3 TSC22D2 MLXIP SHPK NCOA1 KAT6B SMAD3	1.16e-04	184	181	8	1064_DN
Drug	valinomycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	MAP2 DTNA RBM26 TRIM29 ARHGEF11 NUPR1 MOCS1 MRTFA	1.16e-04	184	181	8	5957_UP
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	TSC22D2 RREB1 ARID1A GRHL2 KMT2A LRRC8B KAT6B TRMT12	1.21e-04	185	181	8	1114_DN
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A	ESR1 SMARCAL1 ADGRB2 BCL11A ARHGEF1 UNKL LRRC8B MOCS1	1.21e-04	185	181	8	4327_DN
Drug	0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A	VGF DTNA ESR1 KLF3 POM121L2 GTF3C2 BAZ2A GNAS	1.25e-04	186	181	8	6900_UP
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	SATB2 NUP98 ARID1A UBR5 BAZ2A KMT2A UNKL KAT6B	1.35e-04	188	181	8	4845_DN
Drug	Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A	HIVEP1 ESR1 INPPL1 ETV1 BCL11A BCL9 MED15 RIN1	1.35e-04	188	181	8	5116_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	DTNA ESR1 ASAP3 ARID1A TRIM29 ARHGEF11 KMT2A RERE	1.45e-04	190	181	8	4362_DN
Drug	Astemizole [68844-77-9]; Down 200; 8.8uM; PC3; HT_HG-U133A	DTNA ESR1 POLH ASAP3 ETV1 KMT2A LRRC8B SMAD3	1.50e-04	191	181	8	4471_DN
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	FOXJ2 SATB2 HIVEP1 SMARCAL1 BCL3 MLXIP ARID1A SMAD3	1.56e-04	192	181	8	1638_DN
Drug	Chlorhexidine [55-56-1]; Up 200; 8uM; MCF7; HT_HG-U133A	RAD54L2 NUPR1 CEP164 BAZ2A ARHGEF1 TP63 MTMR3 MRTFA	1.56e-04	192	181	8	1525_UP
Drug	Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; HL60; HT_HG-U133A	MAPKAPK2 DTNA SEC24A KLF3 MED15 BAZ2A BRD4 LRRC8B	1.62e-04	193	181	8	1864_UP
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A	MAPKAPK2 KLF3 IRGQ ARID1A MED15 NOTCH2 MRTFA SMAD3	1.62e-04	193	181	8	6751_DN
Drug	indomethacin, USP; Up 200; 20uM; MCF7; HG-U133A	ESR1 MLXIP ARID1A STAT6 MLXIPL PAX3 RERE SMAD3	1.62e-04	193	181	8	262_UP
Drug	Butoconazole nitrate [32872-77-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A	RBM26 MLXIP TRIM29 NUPR1 RIN1 MLXIPL RERE MOCS1	1.67e-04	194	181	8	3288_UP
Drug	Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A	DTNA ASAP3 ETV1 TSC22D2 STAT6 BRD4 AFDN SMAD3	1.67e-04	194	181	8	3213_UP
Drug	Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	DTNA ESR1 ETV1 BCL9 PKNOX2 TP63 PAX3 RIMS1	1.67e-04	194	181	8	5418_UP
Drug	STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A	DTNA MTSS1 ASAP3 ETV1 TSC22D2 RIMS1 RERE SMAD3	1.67e-04	194	181	8	6380_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A	MAPKAPK2 ADGRB2 RAD54L2 TRIM29 STAT6 GLI2 ARHGEF1 BRD4	1.67e-04	194	181	8	4331_DN
Drug	Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	ASAP3 POM121L2 IRGQ MED15 FGF23 RERE NOTCH2 SMAD3	1.67e-04	194	181	8	4126_DN
Drug	Deferoxamine mesylate [138-14-7]; Down 200; 6uM; PC3; HT_HG-U133A	ASAP3 ADGRB2 POM121L2 TRIM29 RIN1 LRRC8B MOCS1 MRTFA	1.67e-04	194	181	8	4317_DN
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	SATB2 BCAS3 MBNL1 ETV1 RERE GNAS KAT6B NOTCH2	1.67e-04	194	181	8	7538_DN
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; PC3; HT_HG-U133A	VGF MAP2 ESR1 POLH ETV1 BCL11A STAT6 ZFHX2	1.67e-04	194	181	8	4599_DN
Disease	bilirubin measurement	DCHS2 SH2B3 BCAS3 BCL3 MLXIP PKD1L2 RREB1 ARID1A BIRC6 GLI2 MTMR3 LRRC8B	1.79e-05	442	179	12	EFO_0004570
Disease	reticulocyte measurement	FOXO3 SH2B3 PATZ1 USP9X KLF3 PFAS ST6GAL1 BCL11A TSC22D2 RREB1 ATXN1L PLXNB2 BIRC6 MLXIPL FOXP4 BRD4 USP32 MTMR3 AFDN	2.39e-05	1053	179	19	EFO_0010700
Disease	meningitis	CACNA1E RAPH1 RERE	3.49e-05	11	179	3	MONDO_0021108
Disease	cancer	SATB2 ESR1 SMARCAL1 RREB1 TENM2 ARHGEF10L PHC3 FOXP4 SPRY4 SLC45A2 MRTFA	3.59e-05	400	179	11	MONDO_0004992
Disease	myo-inositol measurement	ARHGAP17 SLC5A11	3.66e-05	2	179	2	EFO_0800621
Disease	Sinonasal undifferentiated carcinoma	PAX3 MAML3	3.66e-05	2	179	2	C1710096
Disease	obesity (implicated_via_orthology)	DCHS2 ESR1 ETV1 PLXNB2 MED12L ZFHX2 NCOA1 NOTCH2	5.36e-05	215	179	8	DOID:9970 (implicated_via_orthology)
Disease	proprotein convertase subtilisin/kexin type 7 measurement	SIK3 CEP164 RNF214	1.40e-04	17	179	3	EFO_0008270
Disease	breast carcinoma	PPRC1 BCAS3 ESR1 POM121L2 SIK3 RREB1 GRHL2 MSTO1 LMX1B GLI2 SPRY4 MTMR3 NCOA1 CATSPERB NOTCH2 MRTFA SMAD3	1.67e-04	1019	179	17	EFO_0000305
Disease	reticulocyte count	FOXO3 SH2B3 BCAS3 PATZ1 USP9X KLF3 ST6GAL1 BCL11A TSC22D2 RREB1 ATXN1L PLXNB2 BIRC6 MLXIPL FOXP4 USP32 MTMR3	2.25e-04	1045	179	17	EFO_0007986
Disease	cholesteryl esters to total lipids in IDL percentage	BCL3 SIK3 ARID1A MLXIPL	2.43e-04	50	179	4	EFO_0022247
Disease	depressive symptom measurement	CACNA1E POU6F2 HIVEP1 MBNL1 POM121L2 TENM2 PROX2 KMT2A RERE MAML3	2.93e-04	426	179	10	EFO_0007006
Disease	intraocular pressure measurement	POU6F2 SH2B3 BCAS3 ADGRB2 ETV1 TSC22D2 LMX1B CSPG4 KMT2A ARHGAP20 SMAD3	2.97e-04	509	179	11	EFO_0004695
Disease	glaucoma	POU6F2 SH2B3 BCAS3 TSC22D2 LMX1B KMT2A	3.66e-04	154	179	6	MONDO_0005041
Disease	urate measurement	BCAS3 DTNA ARHGAP17 MLXIP RREB1 ARID1A TRIM29 BIRC6 DYDC2 MLXIPL CACNA2D4 CSPG4 GNAS CCDC17 NOTCH2	3.89e-04	895	179	15	EFO_0004531
Disease	prostate cancer (is_marker_for)	FOXO3 ESR1 STAT6 NCOA1 KMT2A SMAD3	3.93e-04	156	179	6	DOID:10283 (is_marker_for)
Disease	chronic hepatitis B virus infection	TCF19 ETV1 GRHL2	4.05e-04	24	179	3	EFO_0004239
Disease	Cerebral Astrocytoma	ESR1 LATS2 NOTCH2	4.58e-04	25	179	3	C0750935
Disease	Intracranial Astrocytoma	ESR1 LATS2 NOTCH2	4.58e-04	25	179	3	C0750936
Disease	Astrocytoma	ESR1 LATS2 NOTCH2	4.58e-04	25	179	3	C0004114
Disease	Grade I Astrocytoma	ESR1 LATS2 NOTCH2	4.58e-04	25	179	3	C1704230
Disease	Subependymal Giant Cell Astrocytoma	ESR1 LATS2 NOTCH2	4.58e-04	25	179	3	C0205768
Disease	Mixed oligoastrocytoma	ESR1 LATS2 NOTCH2	4.58e-04	25	179	3	C0547065
Disease	Pilocytic Astrocytoma	ESR1 LATS2 NOTCH2	4.58e-04	25	179	3	C0334583
Disease	Juvenile Pilocytic Astrocytoma	ESR1 LATS2 NOTCH2	4.58e-04	25	179	3	C0280783
Disease	Diffuse Astrocytoma	ESR1 LATS2 NOTCH2	4.58e-04	25	179	3	C0280785
Disease	Childhood Cerebral Astrocytoma	ESR1 LATS2 NOTCH2	4.58e-04	25	179	3	C0338070
Disease	Gemistocytic astrocytoma	ESR1 LATS2 NOTCH2	5.15e-04	26	179	3	C0334581
Disease	Protoplasmic astrocytoma	ESR1 LATS2 NOTCH2	5.15e-04	26	179	3	C0334580
Disease	Fibrillary Astrocytoma	ESR1 LATS2 NOTCH2	5.15e-04	26	179	3	C0334582
Disease	Fibroid Tumor	ESR1 SMAD3	5.40e-04	6	179	2	C0023267
Disease	cerebral infarction (implicated_via_orthology)	EPHX2 MAP2	5.40e-04	6	179	2	DOID:3526 (implicated_via_orthology)
Disease	fear of pain measurement	MYOCD TRMT12	5.40e-04	6	179	2	EFO_0008330
Disease	cutaneous melanoma, hair color	RREB1 PLXNB2 SLC45A2 ARHGAP20	5.55e-04	62	179	4	EFO_0000389, EFO_0003924
Disease	Anaplastic astrocytoma	ESR1 LATS2 NOTCH2	5.77e-04	27	179	3	C0334579
Disease	triacylglycerol 54:7 measurement	CACNA2D4 MAGEC1 MAML3	6.43e-04	28	179	3	EFO_0010425
Disease	blood phosphate measurement	FOXO3 BCAS3 ESR1 FGF23 MED23 KNL1	6.98e-04	174	179	6	EFO_0010972
Disease	Carcinoma, Basal Cell	GLI2 SLC45A2 ACTRT1	7.14e-04	29	179	3	C4721806
Disease	Cone-Rod Dystrophy 2	CACNA2D4 AIPL1 RIMS1	7.14e-04	29	179	3	C3489532
Disease	venous thromboembolism, fibrinogen measurement	DCHS2 RAPGEF6 SH2B3 F5	7.45e-04	67	179	4	EFO_0004286, EFO_0004623
Disease	Uterine Fibroids	ESR1 SMAD3	7.53e-04	7	179	2	C0042133
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	BCL3 SIK3 MLXIPL MAML3	8.33e-04	69	179	4	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	neuroimaging measurement	FOXO3 DCHS2 MAP2 RBM26 KLF3 TSC22D2 RREB1 ARHGEF11 PLXNB2 MLXIPL ARHGEF1 TP63 PAX3 RERE ZSWIM4 CRTC2	8.44e-04	1069	179	16	EFO_0004346
Disease	Malignant neoplasm of breast	RAPH1 ESR1 POLH SMARCAL1 NUP98 BCL11A SIK3 ARID1A TRIM29 FOXP4 CLCA2 MTMR3 NCOA1 PACC1 KAT6B NOTCH2	8.86e-04	1074	179	16	C0006142
Disease	myelofibrosis (is_implicated_in)	SH2B3 KMT2A	1.00e-03	8	179	2	DOID:4971 (is_implicated_in)
Disease	NEPHRONOPHTHISIS 2	CEP83 TTC21B	1.00e-03	8	179	2	C1865872
Disease	Acute erythroleukemia - M6a subtype	NUP98 KMT2A	1.00e-03	8	179	2	C2930975
Disease	Acute myeloid leukemia FAB-M6	NUP98 KMT2A	1.00e-03	8	179	2	C2930976
Disease	Acute erythroleukemia - M6b subtype	NUP98 KMT2A	1.00e-03	8	179	2	C2930977
Disease	Acute erythroleukemia	NUP98 KMT2A	1.00e-03	8	179	2	C2930974
Disease	Cornelia De Lange Syndrome	BRD4 KMT2A	1.00e-03	8	179	2	C0270972
Disease	Congenital Hand Deformities	TP63 PAX3	1.00e-03	8	179	2	C0018566
Disease	wellbeing measurement	CACNA1E RAPGEF6 HIVEP1 SH2B3 MBNL1 POM121L2 SIK3 AIPL1 KMT2A RERE MAML3 SMAD3	1.12e-03	692	179	12	EFO_0007869
Disease	creatinine measurement	FOXO3 BCAS3 RREB1 ARID1A PLXNB2 GRHL2 BIRC6 DYDC2 CSPG4 USP32 MTMR3 GNAS MED23 MRTFA SMAD3	1.14e-03	995	179	15	EFO_0004518
Disease	birth weight, parental genotype effect measurement	SH2B3 ESR1 RREB1 NUPR1 USF3 SMAD3	1.16e-03	192	179	6	EFO_0004344, EFO_0005939
Disease	sexual dimorphism measurement	FOXO3 RAPGEF6 ESR1 POM121L2 BCL3 SIK3 RAD54L2 MLXIP ARID1A NUPR1 CEP164 RNF214 MLXIPL ZNF341 GLI2 SMAD3	1.20e-03	1106	179	16	EFO_0021796
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	MAP2 MTSS1 RERE KAT6B SMAD3	1.25e-03	131	179	5	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	MAP2 MTSS1 RERE KAT6B SMAD3	1.25e-03	131	179	5	C4552091
Disease	Juvenile arthritis	MAP2 MTSS1 RERE KAT6B SMAD3	1.25e-03	131	179	5	C3495559
Disease	Juvenile psoriatic arthritis	MAP2 MTSS1 RERE KAT6B SMAD3	1.25e-03	131	179	5	C3714758
Disease	Colorectal Carcinoma	SATB2 MAP2 ASAP3 ETV1 ARID1A F5 ARHGEF10L TRIM28 ARHGEF1 TP63 GNAS SMAD3	1.26e-03	702	179	12	C0009402
Disease	22q11 partial monosomy syndrome	RREB1 SEC24C	1.28e-03	9	179	2	C3266101
Disease	urticaria, response to non-steroidal anti-inflammatory, angioedema	ABI3BP RIMS1	1.28e-03	9	179	2	EFO_0005531, EFO_0005532, EFO_0005533
Disease	post-operative sensory disturbance	ZPLD1 STAT6	1.28e-03	9	179	2	EFO_0005324
Disease	Nephroblastoma	POU6F2 ARID1A TRIM28	1.35e-03	36	179	3	C0027708
Disease	FEV/FEC ratio	FOXO3 DCHS2 MAP2 BCAS3 ETV1 BCL11A RREB1 MEI1 MED15 LMX1B CSPG4 MTMR3 ARHGAP20 CCDC17 MRTFA DEUP1 SMAD3	1.36e-03	1228	179	17	EFO_0004713
Disease	asthma, allergic disease	KLF3 STAT6 RERE SMAD3	1.38e-03	79	179	4	MONDO_0004979, MONDO_0005271
Disease	Juvenile-Onset Still Disease	MAP2 MTSS1 RERE KAT6B SMAD3	1.43e-03	135	179	5	C0087031
Disease	lymphocyte count	HIVEP1 SH2B3 RAPH1 BCAS3 MBNL1 ETV1 KLF3 MS4A12 RREB1 ARHGEF11 PLXNB2 GRHL2 KANSL2 MED12L RERE ARRDC2 NOTCH2 MRTFA KNL1	1.51e-03	1464	179	19	EFO_0004587
Disease	cognitive function measurement, self reported educational attainment	FOXO3 CACNA1E BCL11A BIRC6 TTC21B MAML3 MRTFA KNL1	1.53e-03	355	179	8	EFO_0004784, EFO_0008354
Disease	urea measurement	BCAS3 SLC45A2	1.59e-03	10	179	2	EFO_0011005
Disease	Asymmetric crying face association	RREB1 SEC24C	1.59e-03	10	179	2	C0431406
Disease	level of Triacylglycerol (51:3) in blood serum	SIK3 MLXIPL	1.59e-03	10	179	2	OBA_2045163
Disease	22q11 Deletion Syndrome	RREB1 SEC24C	1.59e-03	10	179	2	C2936346
Disease	serum non-albumin protein measurement	SH2B3 ST6GAL1 BCL3 NUPR1 TP63 MTMR3 AFDN SMAD3	1.70e-03	361	179	8	EFO_0004568
Disease	triacylglycerol 50:3 measurement	SIK3 CACNA2D4 GTF3C2	1.71e-03	39	179	3	EFO_0010410
Disease	total blood protein measurement	SH2B3 ESR1 MBNL1 ST6GAL1 RREB1 TP63 ANO7 AFDN LRRC8B	1.76e-03	449	179	9	EFO_0004536
Disease	monocyte percentage of leukocytes	SH2B3 MAML1 KLF3 MEI1 ARID1A ARHGEF11 MLXIPL SPRY4 NCOA1 LRRC8B RERE ARRDC2	1.77e-03	731	179	12	EFO_0007989
Disease	Disorder of eye	WFS1 CACNA2D4 TTC21B AIPL1 SLC45A2 RIMS1	1.92e-03	212	179	6	C0015397
Disease	trypsin-3 measurement	RREB1 GRHL2	1.94e-03	11	179	2	EFO_0020791
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	SIK3 MLXIPL	1.94e-03	11	179	2	OBA_2045170
Disease	Neoplasm of uncertain or unknown behavior of breast	ESR1 ARID1A NOTCH2	1.98e-03	41	179	3	C0496956
Disease	Breast adenocarcinoma	ESR1 ARID1A NOTCH2	1.98e-03	41	179	3	C0858252
Disease	apolipoprotein A 1 measurement	POU6F2 SH2B3 MBNL1 BCL3 SIK3 TSC22D2 MLXIP ARID1A CEP164 RNF214 KMT2A MED23 CCDC17	2.10e-03	848	179	13	EFO_0004614
Disease	breast cancer (is_implicated_in)	ESR1 ARID1A F5 UBR5 KAT6B	2.26e-03	150	179	5	DOID:1612 (is_implicated_in)
Disease	level of Diacylglycerol (18:1_18:2) in blood serum	SIK3 MLXIPL	2.32e-03	12	179	2	OBA_2045171
Disease	acute myeloid leukemia (implicated_via_orthology)	NUP98 KMT2A	2.32e-03	12	179	2	DOID:9119 (implicated_via_orthology)
Disease	reaction time measurement	FOXO3 SATB2 SH2B3 TENM2 MLXIPL CACNA2D4 BRD4 NCOA1 ANO7 RIMS1 RERE	2.37e-03	658	179	11	EFO_0008393
Disease	neuroticism measurement, cognitive function measurement	FOXO3 CACNA1E POU6F2 HIVEP1 SH2B3 BCL11A TSC22D2 ARID1A BIRC6 RERE	2.50e-03	566	179	10	EFO_0007660, EFO_0008354
Disease	fibrinogen measurement, coronary artery disease	DCHS2 RAPGEF6 SH2B3 RAPH1 SMAD3	2.54e-03	154	179	5	EFO_0001645, EFO_0004623
Disease	alcohol and nicotine codependence	HIVEP1 PKNOX2	2.73e-03	13	179	2	EFO_0004776
Disease	methylcobalamin deficiency type cblE, response to antineoplastic agent	KMT2A LRRC8B	2.73e-03	13	179	2	GO_0097327, MONDO_0009354
Disease	Inhalant adrenergic use measurement	STAT6 SPRY4 RERE SMAD3	2.82e-03	96	179	4	EFO_0009941
Disease	Neuroblastoma	ESR1 ARID1A GNAS	2.93e-03	47	179	3	C0027819
Disease	pneumonia	BCL9L NUPR1 F5	2.93e-03	47	179	3	EFO_0003106
Disease	Schizophrenia	EPHX2 RAPGEF6 ESR1 MBNL1 BCL11A BCL9 ARHGEF11 MED15 PKNOX2 LMX1B KMT2A GNAS MAGEC1	2.97e-03	883	179	13	C0036341
Disease	IGF-1 measurement	FOXO3 ESR1 NUP98 RREB1 ARID1A MLXIPL PHC3 GNAS SMAD3	3.08e-03	488	179	9	EFO_0004627
Disease	dyslexia	FOXO3 POU6F2 SATB2 SH2B3 AIPL1	3.15e-03	162	179	5	EFO_0005424
Disease	Sarcoma, Spindle Cell	PAX3 MAML3	3.17e-03	14	179	2	C0205945
Disease	Sarcoma, Epithelioid	PAX3 MAML3	3.17e-03	14	179	2	C0205944

Protein segments in the cluster

Peptide	Gene	Start	Entry
LSFCPMQPASPGQPL	TTC21B	456	Q7Z4L5
SPLPGNILVPMAASP	ADGRB2	1296	O60241
PAPFSPLTAQQMKPE	AFDN	1451	P55196
MPSPQTDTPGPELQS	EXOC3L4	1	Q17RC7
PLPGFSEPQLPGTMT	CCDC17	356	Q96LX7
PQGPMSLESLAPPES	ARHGEF1	351	Q92888
MASSNPPPQPAIGDQ	ARHGEF10L	1	Q9HCE6
SLMSPLEPGDPSQAP	ASAP3	801	Q8TDY4
MLSQGATQPPAEPPT	AIPL1	326	Q9NZN9
TPLFMTPPLTPPNEA	BIRC6	1701	Q9NR09
PPSNMGIAIPLTDNF	CATSPERB	871	Q9H7T0
IFQLSMSDGASPPLP	CSPG4	1916	Q6UVK1
EAPTMNPLNPLNPLS	CACNA1E	801	Q15878
MTDFLQATQTAPPPP	BAG6	646	P46379
PQQAAPAMKSSPPPF	BRD4	786	O60885
FFQMPSGQLQPNLPP	APOBEC4	271	Q8WW27
NGPPSFFTSPQTSPM	BAZ2A	181	Q9UIF9
FPQPLIDPMPQGHSS	A2ML1	641	A8K2U0
MSPPQPDSLPAGQTE	ARHGEF11	1381	O15085
MFPNSILGRPPFTPN	TENT2	1	Q6PIY7
PNMPPTASINPVSFQ	CEP83	636	Q9Y592
MEALGPGPPASLFQP	AGO4	1	Q9HCK5
PSTNAALPGPPAQLM	RAD54L2	1196	Q9Y4B4
NPSFMLNPSVPGILP	RAD54L2	1366	Q9Y4B4
MFAPFPSPVLPSNLS	RAD54L2	1396	Q9Y4B4
GVPLQSQTAMFLPPT	HSD11B1L	236	Q7Z5J1
NRSTMPPLPPSTFQA	DEUP1	516	Q05D60
NPGNPRLSPLPSLMV	BCAS3	511	Q9H6U6
MPGLVDSNPAPPESQ	COX17	1	Q14061
QSPFPLPQDPDMSLE	ARRDC2	356	Q8TBH0
PPETSQNLNPLTPMA	ATG2B	526	Q96BY7
IQDPQPTPSAPAMGA	AMPH	591	P49418
MSTPAVPQDLQLPPS	CKAP2	1	Q8WWK9
PLQPSGMDAPPNSAT	RBM26	386	Q5T8P6
GALFKPPTPPVMQSQ	RAPH1	681	Q70E73
GPQAQATMTPPPNLT	KAT6B	1871	Q8WYB5
LNSLPTMEGPPTFNP	LGALS4	176	P56470
GQPLARTPQPSSPMD	ARID1A	371	O14497
STGAPQPNLMPSNPD	ARID1A	1301	O14497
PQFAASAPMTAPNPI	ANO7	466	Q6IWH7
MPPTTVILGPSQPQS	DSG2	946	Q14126
SGQPRADNPSPNLMP	MAML1	351	Q92585
TSPGILQASPNPMLA	NOTCH2	2171	Q04721
TAPLPPASQTTPLQM	NUP98	906	P52948
SPPLMNSVSPPQALL	KLF3	216	P57682
SPGPPSVQPTLLDMD	MAP3K10	921	Q02779
QFLTPPQTPTPGESM	NFKBIZ	186	Q9BYH8
PPGPGMSPVQLAFSD	MED12L	336	Q86YW9
PQSPPQGEDSMSPLY	MAGEC1	596	O60732
PEPPLASPQTSQMLV	MAGED4	161	Q96JG8
MLSNSQGQSPPVPFP	MAPKAPK2	1	P49137
LSQGVPGMPAFSQPP	MAML3	1051	Q96JK9
MLVGQPPFLAPTPTE	LATS2	906	Q9NRM7
FLPGTSSLIPGMPQQ	DYDC2	121	Q96IM9
GLPSVVNMSPLPPTF	ATXN1L	96	P0C7T5
QSAPGQMFSTPAIPP	LGALS9	201	O00182
PSPMQRLLQPFQPGS	BCL11A	336	Q9H165
CPQFLGPSPLVIPMN	PLXNB2	666	O15031
GFPPLNSVSPSPLML	ESR1	96	P03372
SQDAFQSKSPSPMPP	MTSS1	326	O43312
SPMPPEAPNQLSNGF	MTSS1	336	O43312
FPLAPGQSLPDSLMQ	MSTO1	376	Q9BUK6
ASQSFPPPLMIKQEP	ETV1	246	P50549
AAVPPQAMNSGSPAP	MED23	1341	Q9ULK4
PMLSSPSPGQQVQTP	MED15	431	Q96RN5
PGPLNTPVNPSSVMS	MED15	506	Q96RN5
SAMVPSQLQLLPPGF	KNL1	86	Q8NG31
PSLLPARQPGFMEPQ	GLI2	1341	P10070
SSFPLLNSPGMLNPG	FOXP4	581	Q8IVH2
PPEGNPQMSLQSPTS	FOXJ2	186	Q9P0K8
SLQSSPIPIASPPQM	PHC3	491	Q8NDX5
ILPGPLSPMQTQFSP	MYOCD	856	Q8IZQ8
SMNTSSNPGTPLPLP	LRRC8B	76	Q6P9F7
FLMFPNSPPANPSIF	MOCS1	386	Q9NZB8
QMRFPTTLPPPSNVG	NUP155	581	O75694
PNLTPSPQPMEDGLL	PKD1L2	1636	Q7Z442
PPSTSSGQPPLQDML	MEI1	1246	Q5TIA1
PSNPMNPTIGNGLSP	PAX3	376	P23760
PPLTSPGQPGDMNCT	PACC1	136	Q9H813
PNFSPSLSLLTMQPP	DCHS2	3326	Q6V1P9
DESSLPLPQPSPFMP	RIMS1	871	Q86UR5
PALGSPFSPQQNMSL	PATZ1	641	Q9HBE1
QNLPTPQGLLMPAPA	PROX2	106	Q3B8N5
TQDLDTPGLPPFCPM	PLA2G4E	41	Q3MJ16
QPFLPVFTMPLLSPS	MLXIP	426	Q9HAP2
MNGLSPTQALPPPLS	TP63	516	Q9H3D4
NQPSEELPDMTTFPP	RGL4	206	Q8IZJ4
GSPLEPGPSLPTMNF	IL37	31	Q9NZH6
PFIPANPNMSPLESI	EPHX2	361	P34913
LVALVPMPSDPPFNT	GRHL2	11	Q6ISB3
MLPPDLGPPSFQNLL	C2orf83	51	Q53S99
MFPVAPKPQDSSQPS	CEP70	1	Q8NHQ1
PTMPATPNFLANPSS	CACNA2D4	16	Q7Z3S7
PPAMNTGGSLPDLTN	CRTC2	266	Q53ET0
PMNPGSPTLPAVKQA	GAB4	361	Q2WGN9
LPGMNPPPYSQFLSR	FGF23	146	Q9GZV9
PRPFLPMSQGPGSNS	BCL9	781	O00512
MAEQTPSRPPNLPGQ	BCL9L	1366	Q86UU0
SFPTPQLSPLPMPGN	BAHD1	346	Q8TBE0
QLSPLPMPGNPADYN	BAHD1	351	Q8TBE0
PLQPVPMFSVAPSLA	MBNL1	111	Q9NR56
LNGFLDTLMSDPPPQ	DTNA	206	Q9Y4J8
DGMQCPPSPLLFDPS	KANSL2	416	Q9H9L4
PLASPFLPASTAPMQ	KMT2A	591	Q03164
PVALPPSSGMFPQLG	KMT2A	3396	Q03164
AMGSPFPLVNLPTPL	BCL3	96	P20749
PMAATGLPPLLPAEN	BICRA	1021	Q9NZM4
GAQPQVLCFSPPSMP	C4orf54	1571	D6RIA3
MQRLPGSQPFGSPLA	SEC24C	101	P53992
PQQTPQDPPLSSDGM	SLC45A2	251	Q9UMX9
PPPYQDSPQMTATAQ	PKNOX2	21	Q96KN3
TPAGPPENVLPLSMA	PPRC1	1021	Q5VV67
SPMGPTSFEFLLPPD	CFAP74	1066	Q9C0B2
MPPPQGDVTALFLGP	IRGQ	1	Q8WZA9
QPPGLSTLQMYPTPN	MTMR3	941	Q13615
PGFLMGDLPAPVTPQ	NUP35	36	Q8NFH5
ELPAMGSPLSPLPNA	ONECUT3	191	O60422
PPSSFMAPGFQQPLG	MS4A12	21	Q9NXJ0
LPPSQPSPTGGLMQR	FOXO3	396	O43524
GQPLSPNMPPDSHIN	GOLM2	291	Q6P4E1
SPMPGQLFGISLPNI	ARHGAP20	356	Q9P2F6
PNPFGDPNLSQPIMP	USP9X	2256	Q93008
MEPPIPQSAPLTPNS	SPRY4	1	Q9C004
GALMSNYSLPPPLPT	TRIM29	381	Q14134
SGPSLPPMPSLQEVD	RIN1	301	Q13671
SSQSMQPPIIPLFPV	RAPGEF6	1001	Q8TEU7
PAPSQFQARMPDSGP	VGF	226	O15240
PTNVTLAQPAMSLPP	TSC22D2	326	O75157
TNLSPALGQMPLSPD	F5	1346	P12259
MATFPPATSAPQQPP	NUPR1	1	O60356
NSQGPPNPMALPSEH	ARHGAP17	731	Q68EM7
QPFISSTPQFLPTPM	SPATA31A6	476	Q5VVP1
MPSSSFLPEANLPPP	SEC24A	121	O95486
PRMPNNSFPPNISTL	NCOA1	501	Q15788
TIPLMPNPGPSSQAA	POU6F2	346	P78424
MVSLPPPQSDVTLPG	FOXN1	1	O15353
DLMQAPGLPGSPAPQ	FOXN1	26	O15353
TPVNMDSPPIALDGP	GNAS	321	Q5JWF2
LQSMPPTQANPALPS	PRR36	431	Q9H6K5
QMALTGISPPLAQSP	SMARCAL1	116	Q9NZC9
PIMSPGLLSPQLSPQ	SATB2	291	Q9UPW6
LQDMSSTAPPAPQPS	INPPL1	286	O15357
LFRQPSNSPPPMSSA	SIK3	741	Q9Y2K2
ASMPSGFQPAQTPDP	SHPK	286	Q9UHJ6
ISPEEIQPNPPSSGM	ST6GAL1	311	P15907
MTLGTPPTLPNFNAL	SCYL2	806	Q6P3W7
MESGTSSPQPPQLDP	SLC5A11	1	Q8WWX8
PAAPLSLTLSQNGMP	SLC5A11	571	Q8WWX8
PPPVSCQMPLLDSNT	TENM2	191	Q9NT68
QAPMSNSPSKPSLPF	POLH	506	Q9Y253
LSGPSPFSMNANLPP	RERE	951	Q9P2R6
LFTMTQSGPSPLQLP	MLXIPL	256	Q9NP71
DFFTNSRLPQPPMPS	MLXIPL	301	Q9NP71
FSPPLPASGPQPSFM	RHBDL1	361	O75783
SQPGSPAPAPSAQMD	MRTFA	691	Q969V6
PMIAPFSSKQTPPPF	POM121L2	591	Q96KW2
GLNLSPPMSPVQLPL	SPICE1	756	Q8N0Z3
PSQQPVLMTEPSLNP	ACTRT1	101	Q8TDG2
NPQSPPPLLASMPAQ	CEP164	1286	Q9UPV0
MNGTELPPPPTFSLV	CLCA2	291	Q9UQC9
PMLPSQGAPQRPLST	TCF19	151	Q9Y242
PPPSETDFMLQVFQP	RNF214	441	Q8ND24
QVFQPSPSLAPRMPF	RNF214	451	Q8ND24
LEPTAPPTMAPGLAQ	ULBP3	206	Q9BZM4
SAFTSLDQPMPQGPP	ZNF341	146	Q9BYN7
PQGPPPVQSSLNMHS	ZNF341	156	Q9BYN7
PTNNSQLGSPSMPPF	ZPLD1	351	Q8TCW7
ESMPFLPQALPTSPP	VEZF1	506	Q14119
PLPQRPMPDQTNTST	ZFHX2	2276	Q9C0A1
PLGPMPNSDIDLSNL	MRPL38	31	Q96DV4
PPTMFVPLSRNPGGN	SPEM2	441	Q0P670
MAASAPPQISLPPFS	RREB1	476	Q92766
GLLSQPPSLNTMSDP	SERPINA11	376	Q86U17
DAGSPNLSPNPMSPA	SMAD3	201	P84022
PPSLGQMSLPFDQPH	STAT6	726	P42226
FSPESMPEPLNGPIN	PFAS	161	O15067
MNGPALQPSSPSSAP	SH2B3	1	Q9UQQ2
SNPLPATVMPPAQGT	SMAP1	251	Q8IYB5
PVGFAQPSFPLLPDM	USF3	2161	Q68DE3
PLPSANSPVNMPTTG	SYNGR4	191	O95473
MQSSINGNPPLPNPF	USP9Y	2246	O00507
LVAPMGSSLQSFPLP	SOCS7	331	O14512
SSAMTPPQQPPPLRS	UNKL	496	Q9H9P5
SPMPSPFQGGSFTLP	MAP2	311	P11137
TNGMFPGDSPLNLSP	TOB1	286	P50616
PGLLDQSNPLSTPMP	GTF3C2	126	Q8WUA4
GSPCMLTQLPDPVPS	TRMT12	81	Q53H54
RGIPFIPMISPSPSQ	ABI3BP	601	Q7Z7G0
EPPQSMPSPATQLGN	ZSCAN5C	21	A6NGD5
SPANSTQSPPMPIYN	HIVEP1	361	P15822
DLPRPIFIPNGMPNT	USP32	1031	Q8NFA0
EPPPMSLPGAGLSSQ	TRIM28	811	Q13263
SPSLPASEEGFQPMP	UBR5	2736	O95071
MDSNTAPLGPSCPQP	WFS1	1	O76024
DGPSLQPTMAPAPEL	ZSWIM4	381	Q9H7M6
DPFQQGLTPPQMPGD	LMX1B	331	O60663
PGNPESGAMTSPNPL	MUS81	436	Q96NY9